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A.    Introduction 
1. Streptomycetes as Producers of Bioactive Secondary 
Metabolites 
Streptomycetes are the most widely studied and well known genus of the actinomycete 
family. They are ubiquitous in nature and are largely responsible, through the secretion of 
chemicals called geosmins, for the earthy smell of soil. In general, the genus Streptomyces is 
characterized as a kind of non-motile, filamentous, aerobic and Gram-positive bacteria 
(Waksman et al., 1943).  
During the complex life cycle (Fig.1.1) of the streptomycetes from a spore to a colony, 
elaborate cell division emerges for adaptation to changes of environment (Hodgson et al., 
1992 and Chater et al., 1996). After a suitable germination trigger, streptomycetes form 
branching filaments of cells, which become a network of strands called a mycelium, similar in 
appearance to the mycelium of some fungi. However, they are true bacteria - prokaryotic 
cells - unlike eukaryotic fungal cells. As colonies grow, the substrate hyphae become densely 
piled up and the growth of aerial hyphae is initiated by responses to nutrient limitation or 
other physiological stresses (Takano et al., 1994 and Chakraburtty et al., 1997), and/or to 
cell density via extracellular signals (Horinouchi et al., 1994 and Willey et al., 1993). 
Streptomycetes reproduce and disperse through the formation of spores, called conidia, from 
sporogenous hyphae, which follows the period of vegetative growth. The sporogenous 
hyphae form spores by simple cross-wall divisions in the top region of aerial filament. 
Noticeably, the creation of spores is distinct from the formation of bacterial endospores. The 
spores are in a semi-dormant stage, which can impart resistance to low nutrient and water 
availability and survive in soil for long periods (Mayfield et al., 1972 and Ensign, 1978).  
The genome size of these high G+C content (61-80 mole %) organisms (Wright et al., 1992) 
was accurately estimated by analysis of macrorestriction fragments of the chromosome with 
pulsed-field gel electrophoresis (PFGE). It is composed of approximately 8,000 kb, twice the 
size of an Escherichia coli chromosome (Kieser et al., 1992). The chromosome of most 
streptomycetes is a linear structure (Lin et al., 1993 and Lezhava et al., 1995) and carries 
proteins covalently bound to both free 5’ ends. Chromosome linearity probably contributes to 
the high toleration for large deletions and amplifications in the chromosome. The frequency 
of spontaneous mutagenesis in streptomycetes is as high as 0.1-1%. Mutagenesis occurs 
more frequently after treatment with mutagenic agents, or interfering with its replication by 
cold shock or protoplasting (Cullum et al., 1988 and Leblond et al., 1990). It is shown by a 
recent report that a spontaneous mutant of Streptomyces ambofaciens, which lost nearly 
quarter of the chromosome, has a genome size of only 6,500 kb (Leblond et al., 1991). Most 
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Streptomyces strains contain linear and/or circular plasmids, nearly all of which are self-
transmissible fertility factors. These plasmids can transfer between different Streptomyces 
strain cells by conjugation with 100% efficiency and spread over a diameter of up to 2 mm to 
result in the formation of “pocks” (Rafii et al., 1988 and Wellington et al., 1988). 
 
 
 
Figure 1.1. The life cycle of Streptomyces strains (Kieser et al., 2000). Under favourable conditions, 
one or two germ tubes emerge from a spore and grow by tip extension and branch formation to give 
rise to substrate mycelium. After about 2-3 days, aerial hyphae grow up to form a spiral syncytium. 
When the grey spore pigment is deposited, cell wall thickening occurs to generate spores in the top 
region of aerial mycelium after 4-10 days. 
 
Because streptomycetes inhabit soil, some of them are phytopathogens, known for attacking 
root vegetables, such as potatoes, beets, radishes, rutabaga, turnips, carrots, and parsnip 
(Lechevalier, 1988 and Kennedy et al., 1980). But comparison with other genus of 
pathogenic actinomycetes, such as Mycobacterium, Actinomadura, Nocardia and 
Actinomyces, streptomycetes are safe to animals and human beings except S. somaliensis, 
an established human pathogen. Streptomycetes can consume almost anything, including 
sugars, alcohols, amino acids, organic acids, and aromatic compounds by producing 
extracellular hydrolytic enzymes. Thus, there is considerable interest in these organisms as 
agents for bioremediation. 
Streptomycetes are most widely known for their ability to synthesize a great number of 
antibiotics and other classes of biologically active secondary metabolites. It is believed that 
antibiotics help streptomycetes compete with other organisms in the relatively nutrient-
depleted environment of the soil by reducing competition. Actinomycetes produce about two-
third of the known microorganism-produced antibiotics and amongst them nearly 80% is 
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made by members of the genus Streptomyces. Many of the metabolites are applied in 
human and veterinary medicine and agriculture, such as anti-parasitic agents, herbicides, 
pharmacologically relevant compound (e.g. immunosuppressants), and several enzymes are 
important in food and other industries. 
As multicellular differentiated prokaryotic organisms, streptomycetes become a good pattern 
for the study of complex regulation of gene expression in space and time, morphogenesis, 
metabolism and the flux of metabolites in developmental biology. And the extensive 
knowledge of Streptomyces genetics, molecular biology and physiology, will provide a 
valuable background to their use for industrial exploitation and clinic utilization as well as 
yielding a wealth of fundamental knowledge of prokaryotic genetics with wide implications. 
 
2. Microbial Polyketide Biosynthesis  
In order to defend their habitat, microorganisms, especially ones that inhabit soil and marine 
environments, produce a wide range of chemicals (Berdy, 1987) that are usually called 
“secondary metabolites” because of the dispensability for the organism’s ontogeny. Some of 
secondary metabolites were usually named as antibiotics because of their complex 
structures resulting in the unusually extensive use in pharmacology for treating infectious 
diseases. Polyketides are one of the most important chemical classes of antibiotics. In 
addition to possessing a wide range of functional and structural diversity, polyketides are 
famous for an extremely rich source of biologically active compounds, including antibacterial 
(erythromycin), antifungal (candicidin), antiparasitic (avermectin), antitumor (epothilone and 
doxorubicin), immunosuppressive (FK 506) and other biological activities (Walsh, 2003) 
(Fig.1.2). 
 
2.1      Genetic Contributions to Understanding Polyketide Biosynthesis 
In the last 25 years, there has been a revolution in the understanding of the processes 
responsible for the maintenance, transmission and expression of genetic information at the 
molecular level. After the discovery of genetic materials, DNA and RNA, the development of 
genetics goes very fast and its explosion of knowledge also advances many other studies, 
such as molecular biology, biochemistry and ecology. Before the 1950s, only a small part of 
antibiotics was isolated. Since the improvement of the methods for isolation and identification 
of chemical compounds, the discovery of news substances potential for drugs has entered a 
new stage. Approximately 70-80% of the antibiotics have been discovered in the recent 50 
years.  
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Figure 1.2. Examples of polyketide metabolites. The structures of polyketides and their biological 
activities are shown together with the producers. 
 
Soon after methods for gene cloning in different organisms were published, the isolation of 
genes for antibiotic biosynthesis attracted more interests in order to enrich the 
understanding of the relationship between chemical structures of compounds and functions 
of the related biosynthetic proteins. Through rugged efforts in the early genetic research, 
some gene clusters responsible for the biosynthesis of polyketide antibiotics were identified 
by comparison the differences in the genome of wild-type strain and mutant blocked in a 
step in the biosynthesis. In succession, the close linkage between genes for self-resistance 
to an antibiotic and some of the biosynthetic genes was disclosed and gave more evidence 
for a most important generalization that most of the biosynthetic genes needed to make a 
particular antibiotic, and antibiotic self-resistance genes locate together with regulator genes 
and transport genes in a single cluster (Chater et al., 1985 and Keller et al., 1997). Analysis 
of the sequences of different cloned biosynthetic gene clusters revealed the conserved 
motifs in the same type of synthase enzymes. And these conserved regions can be used as 
probes to isolate genes for other antibiotics. Up to now, nearly one hundred of the entire 
gene clusters for polyketide antibiotic biosynthesis were cloned and sequenced and the 
largest one covers over 100 kb DNA sequence in chromosome (Hu et al., 1994 and 
Campelo et al., 2002).  
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The potential for producing new “hybrid” polyketide structures by engineering novel 
combinations of polyketide biosynthetic genes from different organisms was demonstrated by 
many publications (Hopwood et al., 1985 and McDaniel et al., 1995 and Staunton et al., 2001 
and Kealey 2003). The study of more polyketide biosynthetic gene clusters will help us 
understand the mechanism of enzymatic synthesis and open a new field of drug discovery. 
 
2.2      Molecular Diversity of Polyketides 
Polyketides are synthesized by multifunctional enzymes called polyketide synthases (PKS) 
in a manner that closely parallels fatty acid biosynthesis. The core of the PKS function is the 
synthesis of long chains of carbon atoms through repetitive Claisen condensation reactions 
by joining together small organic acids, such as acetic and malonic acid, by a ketosynthase. 
The building units, acetate, propionate, malonate or methylmalonate, are activated into the 
form of coenzyme A (CoA) esters, such as acetyl-CoA and malonyl-CoA, before involvement 
in the assembly of the polyketide chain. The most common starter unit, acetyl-CoA, with two 
carbon atoms, is condensed with a malonyl-CoA, with three carbons, to give a chain of four 
carbon atoms with loss of one carbon dioxide. Only two carbons are added into the chain in 
each round of condensation with malonyl-CoA (Fig.1.3A). If the extender unit is 
methylmalonyl-CoA, the “extra” carbon forms a methyl side branch to keep the original 
extension speed in the main chain. Selection of different numbers and types of starter and 
extender units diversifies the structures of the polyketide chains (Hopwood, 2004). 
After every Claisen condensation reaction of the fatty acid biosynthesis, the resulting β-keto 
ester is successively reduced by ketoreduction, dehydration and enoylreduction to give a 
saturated chain. Conversely, the β-keto groups in the growing polyketide chain may be 
untreated, partially or fully reduced, yielding different reduction levels (Fig.1.3B). A keto 
group can be reduced to a hydroxyl group, or successively dehydrated to form a double 
bond between two adjacent carbon atoms, or finally fully saturated with hydrogen atoms by 
“enoyl” reduction of the double bond (Fig.1.3C). PKS can omit this cycle or curtail it after 
some or even all condensation steps. The mode of β-keto processing and the 
stereochemistry of the hydroxyl groups also contribute to the diversity of polyketide 
metabolites. 
After the carbon chain reaches a specific length, it is released from the PKS by thiolysis or 
acyltransfer (Wakil, 1989) and cyclized to give different folding patterns. The “tailoring” 
enzymes, including cyclases, group transferases (e.g. C-, O-, and N-methyltransferases, 
glycosyltransferases, and acyltransferases),  NADP(H)- or FAD(H)-dependant 
oxidoreductases, and cytochrome P450-type oxygenases (Pfeifer et al., 2001), can act on 
the PKS-derived intermediate to yield the final biologically active product. 
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Characteristics of the polyketide biosynthetic processing lead to the huge variation among 
naturally occurring polyketides. 
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Figure 1.3. The chemistry of polyketide chain assembly (Hopwood, 2004).  
A. After activation as the corresponding coenzyme A (CoA) esters, acetic acid and malonic acid are 
attached, by specific acyl transferases, to components of the polyketide synthase (PKS). The 
starter unit acetyl-CoA is attached to the active site (cysteine thiol) of the ketosynthase (KS), 
which catalyzes condensation, and the extender unit malonyl-CoA to a thiol residue of the acyl 
carrier protein (ACP). One carbon from malonyl-CoA is lost as carbon dioxide during the 
condensation to yield a four-carbon chain attached to the ACP. After transfer back of the 
saturated chain from the ACP to the KS, the cycle is then repeated to produce a polyketide chain. 
B. The three-step reductive cycle that converts a keto group to a hydroxyl, then to a double bond, 
and finally to a fully saturated carbon. 
C. A complex polyketide containing keto groups, hydroxyl groups, double bonds and fully saturated 
carbons at different positions.  
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2.3 Classification of Polyketide Synthases  
In analogy to the classification of fatty acid synthases (FAS), PKS have traditionally been 
defined into two classes. The multifunctional modular systems that are responsible for the 
biosynthesis of macrolactones, polyenes and polyethers (Bibb et al., 1989 and Fernandez-
Moreno et al., 1992 and Yu et al., 1994) were designated type I. The fully dissociable 
complex of small, discrete monofunctional proteins that catalyze the biosynthesis of bacterial 
aromatic polyketides is exemplified by the class of type II. In the past decade, as cloning and 
sequencing of more and more PKS genes, especially the discovery of fungal PKS and plant 
PKS, the classes of PKS were redefined and enriched by accession of type III PKS and 
expansion of type I PKS into two subclasses, modular type I PKS and iterative type I PKS 
(Fig.1.4).  
In iterative type II PKS, the active site for each biosynthetic step is encoded in a single gene. 
There is only one set of a heterodimeric ketosynthase (KSα-KSβ) and an acyl carrier protein 
(ACP), that have to operate a specific number of times to build a polyketide chain in correct 
length and subsequent cyclisation, reduction and aromatization are performed by cyclase 
(CYC), KR and aromatase (ARO), respectively. In some type II PKS, the malonyl-CoA:ACP 
acyl transferase (MAT), which catalyzes acyl transfer between malonyl-CoA and the ACP, is 
missing and possibly shared between the PKS and the housekeeping FASs (Revill et al., 
1995). Type II PKS usually catalyze the biosynthesis of a broad range of polyfunctional 
aromatic natural products. 
Type III PKS are homodimeric synthases of the chalcone synthase (CHS) superfamily known 
as CHS-like PKS without traditional ACP and KS domains and use acyl CoA substrates 
directly. Chalcone synthases, the most well-known representatives of this family, are 
ubiquitous in higher plants and provide the starting materials for a diverse set of biologically 
important phenylpropanoid metabolites (Schroder 1999). Type III PKS were traditionally 
associated with plants but recently discovered in a number of bacteria. 
Modular type I PKS presenting at bacterial systems are large multifunctional polypeptides 
arranged in a modular fashion with each module being responsible for one round of chain 
extension and subsequent β-keto processing. Particularly, each active site in modular type I 
PKS is used only once during the polyketide biosynthesis. 
Iterative type I PKS are responsible for the biosynthesis of fungal metabolites such as 6-
methylsalicyclic acid (Shoolingin-Jordan et al., 1999) and lovastatin (Staunton 1998). 
Iterative type I PKS possess only one multidomain protein, in which all the enzyme activities 
are covalently linked together. The single multifunctional protein is used iteratively to catalyze 
multiple rounds of chain elongation and appropriate β-keto processing. Notably, in some 
iterative type I PKS, the one set of catalytic domains is able to vary the reduction level of β-
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keto groups during different extension cycles (Kennedy et al., 1999 and Hendrickson L et al., 
1999). 
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Figure 1.4. Different classes of polyketide synthases. Modular type I PKS consist of multi-domain 
proteins that form a modular unit for each condensation cycle. In iterative type I PKS, one copy of 
each active domain, ketosynthase (KS), malonyl-acetyl transferase (MAT), acyl carrier protein (ACP) 
and optional activites for reduction, ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) 
are assembled in one protein and iteratively used during the biosynthesis. In contrast, active sites of 
type II PKS are encoded in different genes and act in an iterative fashion. Type III CHS-like PKS have 
a simple architecture like CHS (a homodimer of identical KS monomeric domains) with an optional 
chalcone reductase (CHR). TE, thioesterase; CYC, cyclase; ARO, aromatase. 
 
2.4 Modular Type I Polyketide Synthases 
According to their operative mode, PKS can be generally classified into iterative and non-
iterative PKS. Some polyketide synthases, such as bacterial aromatic (type II) PKS, fungal 
and plant PKS, operate in an iterative fashion reminiscent of fatty acid synthases. In these 
systems, catalytic domains are re-used until the polyketide chain has reached its full length. 
In stark contrast, modular type I PKS mostly from bacteria, represent giant multienzyme 
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systems that accommodate distinct active sites for each step of catalysis, and are thus 
considered as non-iterative. This kind of PKS is usually responsible for the synthesis of 
macrolide polyketides, such as erythromycin (Cortés et al., 1990)(Fig.1.2), oleandomycin 
(Swan et al., 1994), avermectin (MacNeil et al., 1994), rapamycin (Schwecke et al., 1995), 
spiramycin (Kuhstoss et al., 1996), FK506 (Motamedi et al., 1997), tylosin (Gandecha et al., 
1997) and nystatin (Zotchev et al., 2000) (Fig.1.5). 
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Figure 1.5. Chemical structures of several macrolide polyketides synthesized by modular type I 
PKS.  
 
In modular type I PKS, catalytic domains are physically grouped into modules that consist of 
a minimal set of domains for chain propagation, usually a ketosynthase (KS), an acyl 
transferase, (AT), and ACP. Additional domains may be present for keto group processing, 
such as ketoreductase (KR), dehydratase (DH), and enoyl reductase (ER). While the first 
module is usually fused to a loading domain at its N-terminus, the last PKS module 
terminates polyketide assembly with an additional down-loading thioesterase (TE) domain 
(Cortés et al., 1990 and Donadio et al., 1991). According to the molecular assembly line 
character of modular PKS, order and architecture of the modules usually reflect the chain 
length as well as reduction degree of the resultant polyketide (Cortés et al., 1990 and 
Donadio et al., 1991). This one-to-one correspondence has been demonstrated 
experimentally (Yu et al., 1999) and provides the basis for rationally engineering type I PKS 
biosynthetic pathways.  
 
Introduction 10
2.4.1 The Erythromycin Polyketide Synthase 
The macrolide antibiotic erythromycin polyketide synthase (Cortés et al., 1990 and Donadio 
et al., 1991), produced by a relative of Streptomyces called Saccharopolyspora erythraea, is 
the prototype of type I PKS. It catalyzes the decarboxylative condensations of six (2S)-
methylmalonyl-CoA extender units with a propionate starter unit to give 6-
deoxyerythronolide B (6-dEB), the aglycon (polyketide) moiety of erythromycin. The entire 
PKS (DEBS, 6-deoxyerythronolide B synthase) comprises three large polypeptides (DEBS1, 
DEBS2 and DEBS3) that together have 28 distinct active sites (Fig.1.6). The genes (eryAI, 
eryAII and eryAIII) encoding these three proteins span 32 kb in the erythromycin (ery) gene 
cluster. DEBS1 contains a loading didomain (AT and ACP), which accepts the starter unit, 
while DEBS3 terminates with a TE domain, which catalyzes the release and cyclisation of 
the completed polyketide chain. Each of the DEBS proteins contains two functional modules 
and the sum of six modules corresponds to six condensation reactions needed to build up 
the polyketide backbone. Module 3 only contains KS, AT and ACP without all reductive 
domains, so the keto group could survive. Module 4 possesses a full set of reductive 
activities (DH+ER+KR) and thus a methylene emerges after the fourth round of 
condensation as expected. Other four modules have only one reductive domain (KR) and 
hence four β-keto groups of the corresponding elongation cycles are converted into hydroxyl 
groups, respectively. The correspondence between the catalytic domain composition of 
consecutive modules in the PKS and the structure of the resulting biosynthetic product 
provided the basis for the “assembly line” model, in which the program for the production of 
polyketides is hardwired into the DNA and expressed in a linear array of active domains.  
Several successful experiments provided strong evidences for this model. When the KR of 
module 5 was removed by deletion of the encoding gene, a keto group survived in the 
resulting erythromycin analogues at the position of the fifth condensation in place of the 
normal hydroxyl group (Donadio et al., 1991). Inactivation of the ER in module 4 by 
mutagenesis resulted in a double bond at the expected position of the resulting product 
(Donadio et al., 1993). Further evidences were provided by experiments of repositioning the 
TE in order to cause premature chain release at the diketide, tetraketide and hexaketide 
stages (Kao et al., 1995 and Kao et al., 1996 and Böhm et al., 1998).  
Besides three big open reading frames (ORFs) for the eryA polyketide synthase genes, 
several genes, including a hydroxylase gene (eryF) (Haydock et al., 1991), O-glycosyl-
transferase genes (eryB and eryC) (Dhillon et al., 1989 and Haydock et al., 1991), a P450 
hydroxylase gene (eryK) (Stassi et al., 1993) and an O-methyltransferase gene (eryG) 
(Haydock et al., 1991), were also found to be involved in the secondary modifications of 
polyketide chain to yield biologically active erythromycin at the end. 
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Figure 1.6. Domain organization of the erythromycin polyketide synthase. Each PKS module 
contains the essential ketosynthase (KS), acyltransferase (AT) and acyl carrier protein (ACP) domains. 
Some modules also have optional β-keto processing activities, like ketoreductase (KR), dehydratase 
(DH) and enoyl reductase (ER). TE, Thioesterase. 
 
2.4.2 Genetic Engineering of Modular Type I Polyketide Synthases 
The direct correspondence between the catalytic domains of modules in a PKS and the 
structure of the resulting biosynthetic product allows rational modifications of the polyketide 
structure by genetic engineering. When targeted changes are made in the genes, expected 
compounds could be produced by the mutated PKS. The strategies available include deletion, 
substitution or addition of catalytic activities by manipulation of corresponding genes. 
Through expression of PKS, exchange of starter units, rearrangement of modules, swapping 
or inactivating of domains or modification of post-PKS processing, unnatural natural products 
could be generated for biological and pharmaceutical applications. 
Because the development of genetic methods in uncharacterized microorganisms remains a 
major technological barrier, a Streptomyces host-vector system ― CH999/pRM5 has been 
developed for efficient construction and expression of recombinant PKS (McDaniel et al., 
1993). The host strain CH999 is a S. coelicolor A3 (2) derivative, from which the entire set of 
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actinorhodin (act) gene cluster (a type II PKS) except for one, actVI-ORFA, at the extreme 
left-hand end of the cluster, has been deleted and replaced by an erythromycin resistance 
gene (Caballero et al., 1991) and the biosynthesis of another pigmented antibiotic, 
undecylprodigiosin, was blocked by a stable mutation. A series of low copy number S. 
coelicolor plasmid SCP2* derivatives carrying the desired sets of PKS subunit genes were 
introduced into CH999 to investigate novel polyketide metabolites. They usually include a 
ColE1 replicon and a selection marker of β-lactamase gene (bla) for genetic engineering in E. 
coli, an appropriately truncated SCP2* Streptomyces replicon and a thiostrepton resistance 
gene (tsr) for selection in Streptomyces. The particular components of these plasmids are 
the actII-ORF4 activator gene from the act cluster, which activates transcription from act 
promoters, and the divergent actI/actIII promoter pair together with convenient cloning sites 
for the insertion of different PKS genes downstream of both promoters. For example, the 
representative plasmid pRM5 (Fig1.7) contains the act KS (KSα), CLF (KSβ), ACP, ARO, 
CYC and KR genes cloned downstream of PactI and PactIII. Other recombinant PKS can 
also be introduced in the same position by exchange of the gene sets. 
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Figure 1.7. Restriction map of the vector pRM5 for expression of recombinant PKS. ori SCP2*, 
origin of replication of SCP2*; ori ColE1, ColE1 origin of replication; bla,  β-lactamase gene from 
pBR327; act, actinorhodin biosynthesis gene; KR, ketoreductase; KS, ketosynthase; CLF, chain-
length factor; ACP, acyl carrier protein; ARO, aromatase; CYC, cyclase. 
 
Three big DEBS genes were cloned into pCK7, a derivative of pRM5, in succession and 
expressed in the host strain S. coelicolor CH999. The recombinant strains produced 
abundant quantities of two polyketides. The major product is 6dEB, while the minor product 
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was identified as 8,8a-deoxyoleandolide, which apparently originated from an acetate starter 
unit instead of the propionate starter in 6dEB biosynthesis (Kao et al., 1994). A new 
approach is to use E. coli strains for expression of PKS proteins (Gokhale et al., 1999). To 
date, single module portions of DEBS have been expressed successfully in E. coli (Khosla, 
2000). 
By feeding experiments or exchange of loading modules, the structural diversity of 
polyketides is also enriched by the involvement of different starter units. Under normal 
conditions in vivo, only propionate units are recruited by the DEBS loading module, but in 
recombinant cells or with the purified PKS in vitro, several other acyl-CoA esters are also 
accepted as starter units (Kao et al., 1995 and Wiesmann et al., 1995). The additional 
feeding of alternative carboxylic acids to the fermentation of S. avermitilis, has also led to a 
number of pharmaceutically useful novel avermectins. It seems that the avermectin-
producing PKS is unusual in being able efficiently to accept numerous C2-branched 
carboxylic acids as alternative starter units when they are added to the culture (Chen et al., 
1989 and Dutton et al., 1991). A famous example is the production of doramectin. When fed 
with cyclohexylcarbonyl CoA, the avermectin PKS uses it as starter unit instead of the 
isobutyrate starter of avermectin and produces a commercial anthelmintic agent, doramectin 
(Cropp et al., 2000). The characteristic of broader selectivity in avermectin PKS could be 
transferred to a heterologous PKS by exchanging its loading module. When the avermectin 
PKS loading module was grafted onto the erythromycin-producing PKS in place of the native 
loading module, novel erythromycins containing unnatural starter units were obtained (Pacey 
et al., 1998).  
Deletion, inactivation and swapping of domains have become the most widely practical 
engineering techniques in PKS. The choice of extender unit by a modular PKS system is 
determined by the AT domain of each module. Replacement of AT domains or changing the 
substrate specificity of the AT domain by site-specific mutation can lead to different 
extenders involved in polyketide biosynthesis. The methylmalonyl-specific AT domain of 
DEBS modules 1 and 2 were replaced with three heterologous malonyl-specific AT domains 
from rapamycin PKS, pikromycin PKS and an uncharacterized PKS. These changes resulted 
in the production of novel erythromycin derivatives, which lack the methyl group at 
corresponding sites of the macrolactone rings (Ruan et al., 1997).  
A promising new approach is to engineer novel combinations of the mutated PKS protein 
subunits. Each of the three DEBS genes were cloned into three compatible streptomyces 
vectors and the genes were introduced in both their native forms and containing a single 
mutation including domain swap or point mutation. 46 of such different triple transformants 
produced detectable levels of polyketide metabolites (Xue et al., 1999). By substituting for 
the AT and beta-carbon processing domains of DEBS with counterparts from different 
Introduction 14
polyketide PKS, a combinatorial library of polyketides was also constructed and more than 
100 macrolide products have been generated by using this simple combinatorial set 
(McDaniel et al., 1999). 
An alterative strategy for mutational engineering polyketides is the combinatorial 
manipulation of larger PKS units, such as the entire modules or the whole protein subunits. 
For example, the recombination between two homologous KR domain-encoding sequences 
resulted in the elimination of one complete module from nystatin PKS, consequently yielding 
a smaller macrolactone (Brautaset et al., 2002). Substitution of DEBS module 2 with module 
5 from the rifamycin PKS created a hybrid DEBS/Rif PKS, which produces the same 6dEB 
product as the native PKS. The domain architecture of PKS suggests that modules begin 
with a KS domain and end in an ACP (Gokhale et al., 1999). Some results from two different 
experiments recently made a new inspect on this view (Ranganathan et al., 1999). A DEBS 
module terminating with an ACP could not communicate effectively with a RAPS (rapamycin 
synthase) module. Indeed, the DEBS ACP required part of its partner KS in the next module 
for transfer of the polyketide chain between the modules. When DEBS module 1 was fused 
to DEBS modules 3 and 6, the investigators found that conservation of the natural linker 
region between modules 1 and 2 gave a functional multienzyme. All these experiments 
showed the importance of the linker region between two modules. 
After the release from the PKS, the polyketide chain is modified by tailoring reactions. Mixing 
and matching of the tailoring enzymes also lead to the production of altered structures 
(Madduri et al., 1998 and Zhao et al., 1999). 
Modular polyketide synthases are potentially valuable for the biosynthesis of novel complex 
polyketides. From domain and module substitutions to module fusion and subunit 
complementation can be used for biosynthesizing new polyketides. As the discovery of more 
and more PKS genes and deeper exploration of the PKS mechanism, genetic engineering 
with combinatorial PKS catches more attention to product numerous novel polyketides 
serving as a source for large libraries of unnatural natural products.  
 
2.5 Some Speculations on the Evolution of Iterative and Non-Iterative PKS 
The most significant distinction between different types of PKS is the operative mode of the 
various catalytic sites, i.e. PKS act either iteratively or non-iteratively in terms of 
programming mechanisms. Iterative PKS including iterative type I PKS, type II and III PKS 
carry a single set of active sites that are used iteratively in successive rounds of chain 
assembly and reduction, while the active sites of non-iterative PKS such as modular type I 
PKS act once in the building of an entire carbon chain. Comparison of different PKS, two 
biochemical features were found to currently correlate with iterative and modular PKS. 
Iterative PKS exclusively employ malonyl-CoA as extender units and usually make very 
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simple reductive changes to the β-keto groups of the polyketide chain. Thus, it seems that 
only a single set of active sites operating in an iterative manner is sufficient for all similar 
rounds of polyketide extension in the iterative synthases. Whereas, modular PKS use at least 
a proportion of more complex chain extenders and have the complicated β-keto processing 
in different elongation cycles of polyketide biosynthesis. Perhaps the complexity of chain 
extender choices and reduction level choices is the selective pressure for modular PKS to 
evolve (Hopwood 1997). Up to now, the molecular basis for iterative or non-iterative action of 
polyketide synthases and their evolutional relationship are still unknown. Studies on the 
precise mechanisms of more PKS, especially those with different characteristics, will enrich 
our understanding of the nascence of PKS and their evolutionary progress, and also 
contribute to the discovery of novel drugs by genetic engineering.  
 
3. Aureothin 
Aureothin is a rare nitrophenyl-substituted polyketide metabolite (Fig.1.8) from the soil isolate 
S. thioluteus (Maeda, 1953) with interesting structural and pharmacological features, such as 
antifungal, insecticidal and weak antitumour properties (Schwartz et al., 1976). The homolog 
neoaureothin, produced by S. orinoci, exhibits antifungal and antiviral activities (Kakinuma et 
al., 1976) and the related pyrone, luteoreticulin, isolated from S. luteoreticuli, possesses 
cytotoxic activity (Suzuki et al., 1976). Interestingly, a closely related derivative, N-acetyl-
aureothamine, recently isolated from S. netropsis (Taniguchi et al., 2000), has been found to 
be a highly selective agent against Helicobacter pylori, the most common cause of chronic 
gastritis.  
Previous feeding experiments with specifically labelled precursors showed that aureothin 
derives from a mixed polyketide pathway (Cardillo et al., 1974 and Yamazaki et al., 1975). In 
fact, the incorporation pattern of 13C-labeled precursors indicated that the aureothin 
backbone is formally assembled from one acetate and four propionate units, possibly by a 
type I PKS (Fig.1.8).  
Aureothin and its homolog neoaureothin are produced by different Streptomyces species, but 
both of them have many identical features in the chemical structures, such as an unusual 
nitroaryl moiety, an O-methylated pyrone and a tetrahydrofuran ring. The difference between 
them is that aureothin has a diene moiety, while neoaureothin has a tetraene system. It is 
tempting to speculate that the biosynthetic pathways of the two compounds are very similar 
and compared to aureothin, neoaureothin could have two more propionate units during the 
polyketide backbone assembly. Molecular analysis of the requisite biosynthetic gene clusters 
will disclose the evolutionary relationship between aureothin and neoaureothin. 
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Figure 1.8. Rare nitrophenyl-substituted polyketide metabolites and derivative produced by 
different Streptomyces strains and the results of previous labeling experiments for aureothin. 
 
The structure of the C7N unit suggests that PABA or a derivative thereof is involved in 
aureothin biosynthesis as a key intermediate. In polyketide biosynthesis, PABA was found to 
act as the starter units in two highly similar heptaene macrolides, candicidin (Campelo et al., 
2002) and FR-008 (Chen et al., 2003). Surprisingly, all efforts to incorporate labeled PABA 
into aureothin failed. Therefore, what is the real starter for the aureothin polyketide chain 
programming? And which gene(s) is(are) responsible for the synthesis of this rare 
nitrophenyl moiety? There is great interest to answer these two questions by biological and 
chemical methods. 
Aureothin contains another two unusual moieties, an exomethylene tetrahydrofuran ring and 
an O-methylated pyrone ring. Up to now, the biosynthetic pathway of this intriguing 
homochiral exomethylene tetrahydrofuran moiety in polyketide biosynthesis is not clear. Also, 
the O-methylated pyrone ring is usually found in aromatic polyketides that are normally 
synthesized by type II PKS (Piel et al., 2000). The study of aureothin gene cluster will also 
help us understanding the biosynthetic mechanism of these unusual structural features. 
 
4. Research Goals 
The special characteristics of the aureothin structure (Fig.1.9) motivated the investigation of 
the aureothin biosynthetic pathway at the biochemical level. The aim of this study was to 
disclose the whole biosynthetic pathway of aureothin, in particular: 
- Primer design and amplification of key genes in aureothin biosynthesis by PCR in order 
to obtain the probes for cloning the aureothin (aur) gene cluster. 
- Cloning of the aureothin biosynthesis gene cluster by construction and screening of a 
genomic library of the aureothin producer, S. thioluteus. 
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Figure 1.9. Special structural characteristics of aureothin. 
 
- Verification of the identity of the cloned aureothin gene cluster either by inactivation of 
some essential genes in wild type strains or by expression of the entire gene cluster in a 
heterologous host. 
- Sequence analysis of the cloned region involved in aureothin biosynthesis. Homology 
analysis with the known genes in databases will indicate the putative functions of some 
gene products in the aureothin biosynthesis gene cluster. 
- Elucidation of the biosynthetic pathway of the rare nitro-phenyl moiety and the starter unit 
of the polyketide programming in aureothin using both molecular and chemical 
approaches.  
- Disclosure of the enzyme(s) that is(are) responsible for the formation of the aureothin 
tetrahydrofuran ring by inactivation and heterologous expression of the putative gene(s). 
- Detection of the enzyme that introduces the methyl group into the pyrone ring by 
inactivation and heterologous expression of the putative gene, and investigation of the 
timing of the tailoring reactions. 
- Investigation of the course of the aureothin polyketide chain assembly by genetic 
engineering of the mutated or hybrid PKS. 
- Production of some new aureothin derivatives with enhanced biological activities by 
engineering approaches. 
Molecular analyses and functional studies of the aureothin biosynthesis gene cluster will 
provide new insights into the machinery and evolution of polyketide synthase and set the 
basis for engineering novel aureothin derivatives. 
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B. Materials and Methods 
1. Materials 
 
1.1 Media 
1.1.1 Media for the Cultivation of Escherichia coli Strains 
 
LB Medium (Sambrook et al., 1989) 
Tryptone 10.0 g, yeast extract 5.0 g, NaCl 10.0 g, agar 15.0 g (optional), purified water 1000 
ml  
 
2 × YT Medium 
Tryptone 16.0 g, yeast extract 10.0 g, NaCl 5.0 g, purified water 1000 ml 
 
SOB Medium (Hanahan, 1983) 
Bacto tryptone 20 g, yeast extract 5 g, NaCl 0.584 g, KCl 0.186 g, pH 7.0 
 
1.1.2 Media for the Cultivation of Streptomyces Strains 
 
M10 Medium 
Yeast extract 4.0 g, malt extract 10.0 g, glucose 4.0 g, agar 20 g (optional), purified water 
1000 ml, pH 7.3 
 
2CM Medium (Yuan, 1983) 
NaCl 1.0 g, K2HPO4 1.0 g, soluble potato starch 10.0 g, inorganic salt solution* 1 ml, 
MgSO4·7H2O 2.0 g, tryptone 2.0 g, CaCO3 2.0 g, (NH4)2SO4 2.0 g, agar 22.0 g, purified water 
1000 ml 
Inorganic salt solution: 
FeSO4·7H2O 1.0 g, MgCl2·6H2O 1.0 g, ZnSO4·7H2O 1.0 g, purified water 1000 ml 
 
R5 Medium (Thompson et al., 1980) 
Sucrose 103 g, K2SO4 0.25 g, MgCl2·6H2O 10.12 g, glucose 10.0 g, Difco casaminoacids 0.1 
g, trace element solution* 2.0 ml, Difco yeast extract 5.0 g, TES 5.73 g, purified water 1000 
ml 
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Aliquots of 100 ml of the solution were poured into 250 ml Erlenmeyer flasks each containing 
2.2 g Difco bacto agar. The flasks were closed and autoclaved. At the time of use, the 
medium was re-melted and mixed with the following sterile solutions in the order listed: 
                                                                KH2PO4 (0.5%) – 1.0 ml  
                                                                CaCl2·2H2O (5 M) – 0.4 ml 
                                                                 L-proline (20%) – 1.5 ml 
                                                                 NaOH (1 M) – 0.7 ml 
Trace element solution: 
ZnCl2 40 mg, FeCl3·6H2O 200 mg, CuCl2·2H2O 10 mg, MnCl2·4H2O 10 mg, Na2B4O7·10H2O 
10 mg, (NH4)6Mo7O24·4H2O 10 mg, purified water 1000 ml 
 
Minimal Medium (MM) (Hopwood, 1967) 
L-asparagine 0.5 g, K2HPO4 0.5 g, MgSO4·7H2O 0.2 g, FeSO4·7H2O 0.01 g, glucose (add 
after autoclaving) 10 g, agar 10 g, purified water 1000 ml, pH 7.0 – 7.2 
 
Soya Flour Mannitol Medium (SFM) (Hobbs et al., 1989) 
Soya flour 20 g, mannitol 20 g, agar 20 g, tap water 1000 ml, pH 7.2 
 
Yeast extract-malt extract medium (YEME)  
Difco yeast extract 3.0 g, Difco bacto-peptone 5.0 g, Oxoid malt extract 3.0 g, glucose 10 g, 
sucrose 340 g, purified water 1000 ml 
After autoclaving, the medium was mixed with the following sterile solutions in the order 
listed: 
                                                                MgCl2·6H2O (2.5 M) – 2 ml (5 mM final) 
                                                                Glycine (20%) – 25 ml (0.5% final) 
Different Streptomyces strains may need different concentrations of glycine; 0.5% is best for 
S. lividans and S. coelicolor. 
 
Double Strength Germination Medium (Kieser et al., 2000) 
Difco yeast extract 1 g, Difco casaminoacids 1 g, CaCl2 (5 M) 200 µl, purified water 100 ml 
 
1.2 Buffers and Solutions 
 
1.2.1 Buffers for Plasmid DNA Preparation from E. coli 
 
Solution I (E. coli cell suspension buffer) (Sambrook et al., 2001)  
50 mM glucose, 25 mM Tris-HCl (pH 8.0), 10 mM EDTA (pH 8.0) 
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The solution was stored at 4°C after autoclaving. 
 
Solution II (E. coli lysis buffer) (Sambrook et al., 2001) 
0.2 M NaOH (fresh diluted from a 10 M stock), 1% (w/v) SDS 
The solution was prepared freshly and used at room temperature. 
 
Solution III (neutralizing buffer) (Sambrook et al., 2001) 
                                                                Potassium acetate (5 M) – 60.0 ml      
                                                                Glacial acetic acid – 11.5 ml 
                                                                Purified water – 28.5 ml 
The resulting solution was 3 M with respect to potassium and 5 M with respect to acetate and 
stored at 4°C. 
 
TE Buffer 
                                                                Tris-HCl (2 M, pH 8.0) – 5 ml 
                                                                Sodium EDTA (0.25 M, pH 8.0) – 4 ml 
                                                                Purified water – 991 ml 
 
1.2.2 Buffers for Protoplast Transformation of Streptomyces 
 
P (Protoplast) Buffer (Okanishi et al., 1974; Hopwood et al., 1978) 
Sucrose 103 g, K2SO4 0.25 g, MgCl2·6H2O 2.02 g, trace element solution 2 ml, purified water 
800 ml 
Aliquots of 80 ml of the buffer were dispensed into flasks and autoclaved. Before use, the 
following sterile solutions were added to each flask in order:  
                                                                KH2PO4 (0.5%) – 1 ml 
                                                                CaCl2·2H2O (3.68%) – 10 ml 
                                                                TES buffer (5.73%, to pH 7.2) – 10 ml 
 
T (Transformation) Buffer (Thompson et al., 1982) 
The following sterile solutions were mixed together:  
                                                                Sucrose (10.3%) – 25 ml 
                                                                Purified water – 75 ml 
                                                                Trace element solution – 0.2 ml 
                                                                K2SO4 (2.5%) – 1 ml 
Then the following sterile solutions were added to 9.3 ml of the above mixture:  
                                                                CaCl2 (5 M) – 0.2 ml 
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                                                                Tris-maleic acid buffer* – 0.5 ml 
Tris-maleic acid buffer: 
Tris 121.14 g, purified water 1000 ml 
The pH number of the buffer was adjusted to 8.0 by adding maleic acid. For use, 3 parts by 
volume of the above solution was added to 1 part by weight of PEG1000 that was previously 
sterilised by autoclaving. 
 
TE25S Buffer 
                                                                Tris-HCl (2 M, pH 8.0) – 12.5 ml 
                                                                Sodium EDTA (0.25 M, pH 8.0) – 100 ml 
                                                                Sucrose – 102.69 g 
                                                                Purified water up to 1000 ml 
This stock solution keeps idefinitely after autoclaving. Just before use lysozyme was 
dissolved in a sample of the solution at a concentration of 2 mg/ml. 
 
1.2.3 Buffers for N-Oxidation Assay 
 
Sodium Chloride Solution (0.85%) 
 
Phosphate-Buffered Saline (PBS) (Sambrook et al., 2001) 
NaCl 8 g, KCl 0.2 g, Na2HPO4 1.44 g, KH2PO4 0.24 g, purified water up to 1000 ml 
The pH number of the buffer was adjusted to 7.0 with HCl. 
 
1.2.4 Buffers for Electrophoresis 
 
50 × TAE Buffer (Hopwood et al., 1985) 
Tris base 242 g, glacial acetic acid 57.1 ml, EDTA ( 0.5M, pH 8.0) 100 ml 
The concentrated buffer was usually diluted into 1 × TAE as working solution. 
 
6 × Gel-loading Buffer (Sambrook et al., 2001) 
Sucrose 40 g, purified water 100 ml, bromophenol blue 0.25 g 
 
1.2.5 Solutions for Preparation of Competent E. coli Cells by Chemical Method 
 
TFB I 
The following sterile solutions were mixed together:  
                                                                Potassium acetate (5 M) – 0.6 ml 
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                                                                CaCl2 (1 M) – 1 ml 
                                                                KCl (1 M) – 10 ml 
                                                                MnCl2 (1 M) – 5 ml 
                                                                 Glycerol (100%) – 15 ml 
                                                                  Purified water – 68.4 ml  
 
TFB II 
The following sterile solutions were mixed together:  
                                                                MOPS (1 M) – 1 ml 
                                                                CaCl2 (1 M) – 7.5 ml 
                                                                KCl (1 M) – 1 ml 
                                                                Glycerol (100%) – 15 ml 
                                                                Purified water – 75.5 ml 
 
1.2.6 Buffers for Hybridization 
 
Denaturation Solution (for neutral transfer, double-stranded DNA targets only) 
NaOH 20 g, NaCl 87.66 g, purified water 1000 ml 
 
Neutralization Buffer 
Tris base 60.57 g, NaCl 58.44 g 
The pH number of the buffer was adjusted to 7.4 with HCl. 
 
20 × SSC  
NaCl 175.32 g, tri-sodium citrate 2-hydreate 88.23 g, purified water 1000 ml 
20 × SSC has 3M NaCl and 0.3 M sodium citrate. The concentrated buffer was usually 
diluted for use as e. g. 1 × SSC, 1.1 × SSC. 
 
Prehybridization and Hybridization Solution 
                                                                20 × SSC – 12.5 ml 
                                                                Blocking Reagent – 0.5 g 
                                                                SDS (10%) – 100 µl 
                                                                Purified water – 37.4 ml 
The solution was prepared at least one hour in advance and blocking reagent was dissolved 
at 65°C. 
 
 
Materials and Methods 23
Maleic acid Buffer   
Maleic acid 11.61 g, NaCl 8.77g, purified water 1000 ml 
The pH number of the buffer was adjusted to 7.5 with NaOH. 
 
Washing Buffer 
0.3 ml Tween 20 was added to 100 ml of maleic acid buffer. 
 
Detection Buffer 
Tris base 12.11 g, NaCl 5.84 g, purified water 1000 ml 
The pH number of the buffer was adjusted to 9.5 with HCl. 
 
Blocking Solution 
1 g blocking reagent was dissolved in maleic acid buffer under 65°C. 
 
Antibody Solution 
Anti-digoxigenin-AP was diluted at 1:5000 (final concentration 150 mU/ml) in blocking 
solution. 
 
Color-substrate Solution   
200 µl of NBT/BCIP was added to 10ml detection buffer. 
 
1.3 Strains and Plasmids 
 
Strains: 
Strain Characteristics 
Reference or 
source 
a) Streptomyces   
S. thioluteus HKI-227 Aureothin producer HKI strain collection
S. lividans ZX1 rec-46  pro-2  str-6  HAU3S Zhou et al., 1988 
S. albus Host strain for expression of PKSs Fierro et al., 1987 
HJ11 S. lividans ZX1::pHJ11  aac(3)IV This study 
HJES S. lividans ZX1::pHJES  aac(3)IV This study 
HJ41 S. lividans ZX1::pHJ41  tsr This study 
HJ43 S. lividans ZX1::pHJ43  tsr This study 
HJSET152 S. lividans ZX1::pSET152  aac(3)IV This study 
HJWHM4* S. lividans ZX1::pWHM4*  tsr This study 
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HJ46 S. lividans ZX1::pHJ46  aac(3)IV This study 
HJ47 S. lividans ZX1::pHJ47  aac(3)IV This study 
HJ48 S. lividans ZX1::pHJ48  aac(3)IV This study 
HJE01 S. lividans ZX1::pHJE01  aac(3)IV This study 
HJ56 S. lividans ZX1::pHJ56  aac(3)IV This study 
HJ60 S. lividans ZX1::pHJ60  tsr This study 
HJ4772 HJ47/pHJ72 aac(3)IV  tsr This study 
HJ78 S. lividans ZX1::pHJ78  tsr This study 
HJ79 S. lividans ZX1::pHJ79  aac(3)IV This study 
HJ82 S. lividans ZX1::pHJ82  aac(3)IV This study 
HJ86ab S. albus::pHJ86  aac(3)IV This study 
HJ95 S. lividans ZX1::pHJ95  tsr This study 
HJ4795 HJ47/pHJ95  aac(3)IV  tsr This study 
HJ97 S. lividans ZX1::pHJ97  aac(3)IV This study 
HJ98 S. lividans ZX1::pHJ98  aac(3)IV This study 
HJ110 S. lividans ZX1::pHJ110  tsr This study 
HJ111 S. lividans ZX1::pHJ111  aac(3)IV This study 
HJ11143 HJ111/pHJ43  aac(3)IV  tsr This study 
HJ125 S. lividans ZX1::pHJ125  aac(3)IV This study 
HJ126 S. lividans ZX1::pHJ126  aac(3)IV This study 
HJ127 S. lividans ZX1::pHJ127  aac(3)IV This study 
HJ125ab S. albus::pHJ125  aac(3)IV This study 
HJ126ab S. albus::pHJ126  aac(3)IV This study 
HJ127ab S. albus::pHJ127  aac(3)IV This study 
HJ128 S. lividans ZX1::pHJ128  aac(3)IV This study 
HJ129 S. lividans ZX1::pHJ129  aac(3)IV This study 
HJ130 S. lividans ZX1::pHJ130  aac(3)IV This study 
HJ134 S. lividans ZX1::pHJ134  tsr This study 
HJ137 S. lividans ZX1::pHJ137  aac(3)IV This study 
HJ144 S. lividans ZX1::pHJ144  aac(3)IV This study 
HJ146 S. lividans ZX1::pHJ146  aac(3)IV This study 
HJ137ab S. albus::pHJ137  aac(3)IV This study 
HJ144ab S. albus::pHJ144  aac(3)IV This study 
HJ146ab S. albus::pHJ146  aac(3)IV This study 
b) Escherichia coli   
EPI100TM F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80d/lacZ ∆M15 
∆lacX74 recA1 endA1 araD139 ∆(ara, leu)7697 galU  
EPICENTRE 
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galK λ- rpsL nupG 
DH5α SupE44  ∆lacU169 (Φ80 lacZ∆M15) hsdR17 recA1 
endA1 gyrA96 thi-1 relA1 
Hanahan, 1983 
ET12567/pUZ8002 RecF dam- dcm- cml str tet km MacNeil et al., 1992
BW25113/pIJ790 ∆(araD-araB)567  ∆lacZ4787(::rrnB-4)  lacIp-
4000(lacIQ) λ-  rpoS369(Am)  rph-1 ∆(rhaD-rhaB)568  
hsdR514   
pIJ790: oriR101  repA101(ts)  araBp-gam-bet-exo  cat 
Gust et al., 2003 
 
Usual vectors: 
Vector Size (kb) Replicon Characteristic/ Origin Reference 
pSET152 5.5 pUC18 oriT RK2 intΦC31 attPΦC31 lacZα aac(3)IV Bierman et al., 1992
pBluescript 
KS- 
3.0 ColE1  lacZα orif1 bla Alting-Mees et al., 
1989 
pRM5 ~27 ColE1 
SCP2* 
bla tsr cos McDaniel et al., 
1993 
pWHM4* 7.9 pUC19 
pIJ101 
lacZ bla tsr PermE* Matseliukh, 2001 
 
Plasmids/Cosmids: 
Construct Size (kb) Vector Insert Resistance 
pPAB1 4.0 pGEM-T Easy 1.0 kb PCR fragment (pabAB primer) from S. thioluteus (template) Amp
R
pKS1 3.7 pGEM-T Easy 0.7 kb PCR fragment (KS primer) from S. thioluteus (template) Amp
R
pPAB181 4.0 pGEM-T Easy 1.0 kb PCR fragment (pabAB primer) from cosmid 18E4 (template) Amp
R
pKS181 3.7 pGEM-T Easy 0.7 kb PCR fragment (KS primer) from cosmid 18E4 (template) Amp
R
pHJS18 11.5 pWEBTM 3.5 kb fragment from cosmid 18E4 SacI-digested and self-ligation Amp
R
pHJ1 10.4 SuperCos1 2.5 kb BamHI fragment from pHJS18 AmpR
pHJ2 8.4 SuperCos1 0.5 kb BamHI fragment from pHJS18 AmpR
pHJ3 8.4 SuperCos1 0.5 kb BamHI fragment from pHJS18 AmpR
Cosmid 
Library Ca. 48 pWEB
TM Ca. 40 kb fragments from  
S. thioluteus Amp
R
Shotgun 
Library Ca. 5.5 pBluescript SK- 2.5 kb fragments from cosmid 18E4 Amp
R
pHJBamHI# 9.7~5.39 pBluescript SK- BamHI fragments from cosmid 18E4 AmpR
pHJSacI# 7.08~1.2 pBluescript SK- SacI fragments from cosmid 18E4 AmpR
pHJ11 Ca. 48 pSET152 Ca. 40 kb SspI fragment ( Insert and Cos site) from cosmid 18E4 Am
R
pHJ12 Ca. 48 pSET152 Ca. 40 kb SspI fragment ( Insert and Cos site) from cosmid 18E4 Am
R
pHJ13 Ca. 48 pAY1 Ca. 40 kb SspI fragment ( Insert and Cos site) from cosmid 18E4 Am
R
pHJEco72I ~20 pSET152 ~20 kb Eco72I fragment from pHJ11 and self-ligation Am
R
pHJ31 3.8 pGEM-T Easy 0.8 kb PCR product (the first part of aurA) from pHJSacI3b (template) Amp
R
pHJ32 8.7 pHJ31 4.9 kb Bsp1407I-NcoI fragment from pHJ11  Amp
R
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pHJ33 ~22 pRM5/PacI-EcoRI 
5.7 kb PacI-NcoI fragment from pHJ32 
and 0.7 kb NcoI-EcoRI fragment from 
pHJ34 
AmpR, ThioR
pHJ34 3.7 pGEM-T Easy 0.7 kb PCR product ( TE domain of aurC) from pHJBamHI1 (template) Amp
R
pHJ35 10.5 pHGF7505 6.4 kb PacI-EcoRI fragment from pHJ33 Amp
R
pHJ36 ~21 pRM5/HindIII-EcoRI 
7.9 kb HindIII-EcoRI fragment from 
pHJ35 Amp
R, ThioR
pHJE72I ~35 pKJ1 ~20 kb Eco72I fragment from pHJ11 AmpR, ThioR
pHJES 23.35 pSET152 17.85 kb Eco72I-SspI fragment from cosmid 18E4 
AmR
pHJ38 5.76 pBluescript SK- 2.758 kb PstI fragment from cosmid 
18E4 Amp
R
pHJ40 12 pHJ35 1.5 kb NdeI-SpeI fragment from plig2 
(from Traitcheva) Amp
R
pHJ41 ~22 pRM5/HindIII- 
EcoRI 
9.4 kb HindIII-EcoRI fragment from 
pHJ40 Amp
R, ThioR
pHJ42 13.9 pHJ40/PacI-
EcoRI 
5.7 kb PacI-NcoI fragment from pHJ32 
and 2.6 kb NcoI-EcoRI fragment from 
pHJ38 
AmpR
pHJ43 ~25 pRM5/HindIII-
EcoRI 
11.3 kb HindIII-EcoRI fragment from 
pHJ42 Amp
R, ThioR
pHJ44 ~37 cosmid 18E4 1.0 kb and ~10 kb XhoI fragments 
were deletion and self-ligation Amp
R
PHJ45 ~47 cosmid 18E4 1.0 kb XhoI fragment was deletion and 
self-ligation Amp
R
pHJ46 ~36 pSET152 ~30 kb SspI fragment from pHJ44 AmR
pHJ47 ~46 pSET152 ~40 kb SspI fragment from pHJ45 AmR
pHJ48 35.3 pSET152 29.8 kb EcoRV fragment from cosmid 
18E4 Am
R
pHJ49 ~45 pHJ11 3.4 kb SgfI fragment was deleted from 
pHJ11 Am
R
pHJ50 ~47 pHJ49 2.6 kb SgfI fragment from pMP15 
(from Palzer) Am
R
pHJ56 ~19 pHJES/KpnI-
EcoRI partial 
3.2 kb KpnI-EcoRI fragment from 
pHJ33 Am
R
pHJE01 20 pHJES 3.4 kb SgfI fragment was deleted from 
pHJES Am
R
pHJ57 4.024 pGEM-T Easy 1.024 kb PCR product (aurF) from 
pHJSacI3d (template) Amp
R
pHJ58 4.172 pGEM-T Easy 1.172 kb PCR product (aurF) from 
pHJBamHI3a (template) Amp
R
pHJ60 9.1 pWHM4* 1.2 kb EcoRI fragment from pHJ58 AmpR, ThioR
pHJ72 9.75 pWHM4* 1.85 kb EcoRI fragment from 9A6 
(from Hertweck) Amp
R, ThioR
pHJ73 18.0 pBluescript SK- 15 kb KpnI fragment from pHJ48 AmpR
pHJ74 4.04 pGEM-T Easy 1.037 kb PCR product (TE) from 
pHJBamHI1 (template) Amp
R
pHJ75 3.68 pGEM-T Easy 0.677 kb PCR product (Short) from 
pHJBamHI1 (template) Amp
R
pHJ76 3.27 pGEM-T Easy 0.272 kb PCR product (Linker region 
of module 3 and 4) from pHJBamHI1 Amp
R
pHJ77 ~48 pHJ48 Double crossover mutant (∆aurF) with 
aadA cassette Am
R, SpcR
pHJ78 ~22 pHJ41/PacI-
EcoRI 
1.0 kb PstI-EcoRI fragment from 
pHJ74 and 5.46 kb PacI-PstI fragment 
from pHJ41 
AmpR, ThioR
pHJ79 ~47 pHJ77 addA cassette was deleted from 
pHJ77 Am
R
pHJ80 5.3 pBluescript SK- 1.276 kb BamHI-FspI fragment from AmpR
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pHJBamHI1 
and 1.0 kb FspI-EcoRI fragment from 
pHJ74 
pHJ81 4.25 pBluescript SK- 0.246 kb BamHI-FspI fragment from 
pHJBamHI5b 
and 1.0 kb FspI-EcoRI fragment from 
pHJ74 
AmpR
pHJ82 14.3 pHJ48 3.5 kb KpnI-XbaI fragment from pHJ78 AmR
pHJ83 14.4 pHJ73/SgfI- 
PstI partial 
0.27 kb PstI-SgfI fragment from pHJ76 AmpR
pHJ84 5.95 pHJ80 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ85 4.92 pHJ81 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ86 31.5 pHJ48/KpnI 11.4 kb KpnI fragment from pHJ83 AmR
pHJ87 8.3 pHJ84 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
pHJ88 7.28 pHJ85 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
pHJ91 3.73 pGEM-T Easy 0.731 kb PCR product (aurI) from 
pHJBamHI1 (template) Amp
R
pHJ92 ~48 pHJ48 Double crossover mutant (∆aurG) with 
aadA cassette Am
R, SpcR
pHJ93 ~48 pHJ48 Double crossover mutant (∆aurH) with 
aadA cassette Am
R, SpcR
pHJ94 4.53 pBluescript SK- 0.533 kb NotI-FspI fragment from 
pHJBamHI4b and 1.0 kb FspI-EcoRI 
fragment from pHJ74 
AmpR
pHJ95 8.64 pWHM4* 0.74 kb EcoRI fragment from pHJ91 AmpR, ThioR
pHJ96 5.2 pHJ94 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ97 ~47 pHJ48 addA cassette was deleted from 
pHJ92 Am
R
pHJ98 ~47 pHJ48 addA cassette was deleted from 
pHJ93 Am
R
pHJ99 7.56 pHJ96 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
pHJ106 4.09 pGEM-T Easy 1.086 kb PCR product (eryTE) from 
Saccharopolyspora erythraea Amp
R
pHJ107 ~43 pHJ48 Double crossover mutant (∆aurA) with 
aadA cassette Am
R, SpcR
pHJ108 4.43 pGEM-T Easy 1.436 kb PCR product (aurH+RBS) 
from pHJBamHI2 (template) Amp
R
pHJ109 4.34 pGEM-T Easy 1.344 kb PCR product (aurH) from 
pHJBamHI2 (template) Amp
R
pHJ110 9.4 pWHM4* 1.4 kb EcoRI fragment from pHJ108 AmpR, ThioR
pHJ111 ~42 pHJ48 addA cassette was deleted from 
pHJ107 Am
R
pHJ112 4.5 pBluescript SK- 0.533 kb NotI-FspI fragment from 
pHJBamHI4b and 1.0 kb FspI-PstI 
fragment from pHJ106 
AmpR
pHJ113 4.25 pBluescript SK- 0.246 kb BamHI-FspI fragment from 
pHJBamHI5b and 1.0 kb FspI-PstI 
fragment from pHJ106 
AmpR
pHJ114 5.3 pBluescript SK- 1.276 kb BamHI-FspI fragment from 
pHJBamHI1 and 1.0 kb FspI-PstI 
fragment from pHJ106 
AmpR
pHJ116 5.2 pHJ112 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ117 4.9 pHJ113 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ118 5.95 pHJ114 0.67 kb HindIII-XhoI fragment from 
pHJ75 Amp
R
pHJ119 7.56 pHJ116 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
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pHJ120 7.28 pHJ117 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
pHJ121 8.3 pHJ118 2.36 kb SmaI fragment from pIJ4642 AmpR, SpcR
pHJ125 24.4 pHJ48 Double crossover mutant (aurA+TE) 
with aadA cassette from pHJ99 Am
R, SpcR
pHJ126 34.3 pHJ48 Double crossover mutant (aurB+TE) 
with aadA cassette from pHJ88 Am
R, SpcR
pHJ127 37.7 pHJ48 Double crossover mutant (aurC1+TE) 
with aadA cassette from pHJ87 Am
R, SpcR
pHJ128 24.4 pHJ48 Double crossover mutant 
(aurA+eryTE) with aadA cassette from 
pHJ119 
AmR, SpcR
pHJ129 34.3 pHJ48 Double crossover mutant 
(aurB+eryTE) with aadA cassette from 
pHJ120 
AmR, SpcR
pHJ130 37.7 pHJ48 Double crossover mutant 
(aurC1+eryTE) with aadA cassette 
from pHJ121 
AmR, SpcR
pHJ133 6.9 pET-15b 1.2 kb NdeI-BamHI fragment from 
pHJ109 Amp
R
pHJ134 9.4 pWHM4* 1.5 kb BglII-BamHI fragment from 
pHJ133 Amp
R
pHJ135 3.328 pGEM-T Easy 0.328 kb PCR product (Linker aurC1-
aurC2) from pHJBamHI1 (template) Amp
R
pHJ136 7.8 pHJ73/AccIII- 
PstI partial 
0.328 kb PstI-AccIII fragment from 
pHJ135 Amp
R
pHJ137 25 pHJ48/KpnI 4.8 kb KpnI fragment from pHJ136 AmR
pHJ139 3.688 pGEM-T Easy 0.688 kb PCR product (EcoRI-AflIII) 
from pHJBamHI1 (template) Amp
R
pHJ140 4.1 pGEM-T Easy 1.100 kb PCR product (AflIII-XbaI) 
from pHJBamHI1 (template) Amp
R
pHJ141 4.448 pGEM-T Easy 1.448 kb PCR product (KpnI-PvuII) 
from pHJBamHI1 (template) Amp
R
pHJ142 4.936 pGEM-T Easy 1.936 kb PCR product (PvuII-XbaI) 
from pHJBamHI1 (template) Amp
R
pHJ143 4.79 pBluescript SK- 0.688 kb EcoRI-AflIII fragment from 
pHJ139 and 1.1 kb AflIII-XbaI fragment 
from pHJ140 
AmpR
pHJ144 ~45 pHJ48/Bsu36 I-
XbaI 
1.159 kb Bsu36I-XbaI fragment from 
pHJ143 Am
R
pHJ145 6.185 pBluescript SK- 1.249 kb KpnI-PvuII fragment from 
pHJ141 and 1.936 kb PvuII-XbaI 
fragment from pHJ142 
AmpR
pHJ146 ~48 pHJ48/Bsu36 I-
KpnI partial 
3.121 kb KpnI-Bsu36I fragment from 
pHJ145 Am
R
 
1.4 Antibiotics and Enzymes 
 
Antibiotics: 
Working concentration (µg/ml) 
Streptomyces Name and 
abbreviation 
Stock 
solution 
(mg/ml) Solid Liquid
Overlay 
(1 ml ddH2O)
E.coli 
Company 
Ampicillin (Amp) 100 ― ― ― 100 Roth 
Apramycin (Am) 50 30 30 1 mg 50 Sigma 
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Kanamycin (Km) 50 25 25 0.5 mg 50 Sigma 
Thiostrepton(Thio) 25 25 5 0.1 mg ― Calbiochem 
Chloramphenicol (Cml) 25 ― ― ― 25 Roth 
Spectinomycin (Spc) 50 20 ― ― 50 Sigma 
Nalidixic acid 50 ― ― 1 mg ― Sigma 
―: undone or no record. 
 
Enzymes: 
Enzyme Reaction Buffer Company 
AccIII F Promega 
AflIII NEBuffer 3 + BSA New England Biolads 
BamHI BamH I NEBuffer + BSA New England Biolads 
BglII NEBuffer 3 New England Biolads 
Bsu36I NEBuffer 3 + BSA New England Biolads 
Eco72I Buffer Tango Fermentas 
EcoRI EcoR I NEBuffer New England Biolads 
EcoRV NEBuffer 3 + BSA New England Biolads 
FspI NEBuffer 4 New England Biolads 
HindIII NEBuffer 2 New England Biolads 
KpnI NEBuffer 1 + BSA New England Biolads 
NcoI NEBuffer 4 New England Biolads 
NdeI NEBuffer 4 New England Biolads 
NotI NEBuffer 3 + BSA New England Biolads 
PacI NEBuffer 1 + BSA New England Biolads 
PstI NEBuffer 3 + BSA New England Biolads 
PvuII NEBuffer 2 New England Biolads 
SacI NEBuffer 1 + BSA New England Biolads 
SacII NEBuffer 4 New England Biolads 
SmaI NEBuffer 4 New England Biolads 
Ssp I Ssp I NEBuffer New England Biolads 
SwaI NEBuffer 3 + BSA New England Biolads 
XbaI NEBuffer 2 + BSA New England Biolads 
XhoI NEBuffer 2 + BSA New England Biolads 
T4 DNA Ligase 1 x T4 DNA Ligase Buffer New England Biolads 
Shrimp Alkaline Phosphatase (SAP) 1 x SAP Buffer Promega 
Proteinase K P buffer or TE25S Promega 
Taq DNA Polymerase 1 x PCR Buffer Amersham 
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1.5 PCR Primers 
Primer Generation of Sequence (5'─ 3') 
KSF1 N-terminal region of KS MGNGARGCNNWNSMNATGGAYCCNCARCANMG 
KSR1 C-terminal region of KS GGRTCNCCNARNSWNGTNCCNGTNCCRTG 
PABAF1 N-terminal region of pabAB GACAACTACGACWSSTTCACS 
PABAR1 C-terminal region of pabAB CCTTSRKCTCGTAGCCSAG 
PABAF2 N-terminal region of pabA GACAACTACGACTCGTTCACC 
PABAR2 C-terminal region of pabA GACGATCATCAGGTTCTCG 
PABAF3 N-terminal region of pabAB CTSGGCGTSTGCCTSGGC 
PABAR3 C-terminal region of pabAB TGTTSGTSAGGCASAYCTCG 
TEL1 N-terminal region of TE 
GCGGCCATGGGCGCGAAACTGATCTGCTTCCCG 
               NcoI 
TER1 C-terminal region of TE GTGGTGGTCATTTTGTTCCTGTCG 
PrimerFL1 N-terminal region of aurF 
GAATTCCATATGCGAGAAGAGCAGCCGCACT 
  EcoRI      NdeI 
PrimerFL2 N-terminal region of aurF 
GAGCGGGAATTCCATATGCCACGACACCGCGGG 
                   EcoRI     NdeI 
PrimerFR C-terminal region of aurF 
GGGGATCCACGCGGCGTCGGGGTCAACG 
       BamHI 
aurFL Deletion of aurF 
CCGCGGTGGGCACGGGCGACGAGGTCGGGAGAGA
CGATGATTCCGGGGATCCGTCGACC 
aurFR Deletion of aurF 
CGGGCTCCGGTCGTGGAGGTCGACGCGGCGTCGG
GGTCATGTAGGCTGGAGCTGCTTC 
aurATEL N-terminal region of TE 
CGCTGCAGCTGCGCAACCGCCTCGGGGC 
          PstI           FspI 
aurATER 
C-terminal region of TE and 
inactivation of ACP4 
GTGTCTAGACGTGCTTGCGCTGGTGGTGGTC 
           XbaI 
LinkerL 
Linker region of module 3 
and 4 
GCGCTGCAGCTGCGCAACCGGCTCGACG 
            PstI 
LinkerR 
Linker region of module 3 
and 4 
GCGATCGCGTCGCGTCCCGAGGCGACCA 
       SgfI 
LinkerR2 
Linker region of module 3 
and 4 
TCCGGATCCGGGTCGTAGAGGCCCTCGAC 
   AccIII BamHI 
ShortL Part of module 4 
CGCAAGCTTCACCCCGTCCTGGCACTGA 
          HindIII 
ShortR  Part of module 4 
GCCCTCGAGAGTTCGGGGCGCTCCTCCAC 
            XhoI 
PrimerA 
Sequencing of aurA+TE 
fusion region 
GACGACACCCTGGCCGACCGCCTG 
PrimerIL N-terminal region of aurI CCCGACACCGACAGGAACAAAATG 
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PrimerIR C-terminal region of aurI CGCTCCCCCGGTATTTGTCAG 
aurGL Deletion of aurG 
AGGACGACCCCGCTCGAACCGACAGGGAGGCTCC
CGATGATTCCGGGGATCCGTCGACC 
aurGR Deletion of aurG 
CTTGAAGCCCGTCGAACGACGGGCGGAACGGCCGT
ACTATGTAGGCTGGAGCTGCTTC 
aurHL Deletion of aurH 
CGGCAGCGCGCCCGTACGCCAACGGAAGGATCGA
ACATGATTCCGGGGATCCGTCGACC 
aurHR Deletion of aurH 
GACGGTGGCGCCGCACCCCCGGCGGCCCGGGAAA
CGTCATGTAGGCTGGAGCTGCTTC 
aurAL Deletion of aurA 
GACCGGCCGCCTCACCCTGCCAGGAAGGAAGCGAT
GATGATTCCGGGGATCCGTCGACC 
aurAR Deletion of aurA 
ATCGGGAGCCTCCCTGTCGGTTCGAGCGGGGTCGT
CCTATGTAGGCTGGAGCTGCTTC 
PrimerHL1  N-terminal region of aurH GCCGTTCCGCCCGTCGTTCG 
PrimerHL2 N-terminal region of aurH 
GAATTCCATATGTCGACCACCGCTCACACCG 
  EcoRI      NdeI 
PrimerHR C-terminal region of aurH 
GGATCCATTCGAGCGTCTTGGCGTCATTGG 
  BamHI 
PrimerEryL N-terminal region of eryTE CGGGAGATGACGTCGCAGGAGTTG 
PrimerEryR N-terminal region of eryTE GTCGTGGTCATGAATTCCCTCCGCCC 
forKpnI Inactivation of KS4 GCCGCCGCCGAGGATGAAGG 
PvuIIrev Inactivation of KS4 
GGCAGCTGTGTCGACCGTGATGGCCGGGCCTTC 
         PvuII 
PvuIIfor Inactivation of KS4 
ACAGCTGCCTCCTCGTCCCTCGTCGCCCTCCAC 
      PvuII 
XbaIrev Inactivation of KS4 
TCTAGATCGGGGAGCGGGGTTTCGTC 
   XbaI 
EcoRIfor Inactivation of ACP4 
GAATTCGTGGCGCTGTACCGGCTGTTGG 
  EcoRI 
AflIIIrev Inactivation of ACP4 
GTCAACGCGTCGAAGCCCAGCTCGGGGAGC 
              AflIII 
AflIIIfor Inactivation of ACP4 
TCGACGCGTTGACCGCGGTGGACCTGCGCAAC 
           AflIII 
 
1.6 Special Devices 
Equipment Company 
Pippete   Research R variabel 3111 Eppendorf 
               Mehrkanalpipette Research R multi 3114 Eppendorf 
               EasyPet Eppendorf 
               Multipette plus Eppendorf 
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Vortex-Genie2 Scientific Industries 
Centrifuge    Minizentrifuge "Dual Rotor" Qualitron Inc. 
                    Centrifuge 5415 R Eppendorf 
                    Centrifuge 5415 D Eppendorf 
Centrifuge 5810 R Eppendorf 
                    Sorvall R RC 5C Sorvall 
pH-Meter Schott 
pH-Eletrode BlueLine 14 Schott 
BioPhotometer Eppendorf 
Speedvaccum Concentrator 5301 Eppendorf 
Electrophoresis chambers Amersham and Biorad 
Power supply    Electrophoresis Power Supply EPS 301 Amersham 
                          PowerPac Basic TM Biorad 
Analytical balances   BP3100S Sartorius 
                                  BP211D Sartorius 
Orbital incubator   Multitron INFORS 
96 well-plate-shaker Edmund Bühler 
Water bath 1083 GFL 
PCR machine   Mastercycler Gradient Eppendorf 
                         Mastercycler Personal Eppendorf 
CL-1000 Ultraviolett-Crosslinker UVP 
Heat/Agitation plate Heidolph 
Gel documentation analysis  Gene Genius Synene 
Water purification  Purelab TM plus USF 
Incubator  B 6120 Heraeus Instruments 
Hybridization oven Binder 
Rotation evaporator Heidolph 
Rocker shaker  Polymax 1040 Heidolph 
Blowtorch Burner  Gasprofi 1 WLD-Tec 
Digital photographic system  Folio Severin 
Microflow (Biological Safety Cabinet) NUNC 
Thermo incubator   Thermomixer comfort Eppendorf 
                               ThermoStat plus Eppendorf 
                               Block Heater Stuart Scientific 
UV-lamp FAUST 
Foto-Analysis  Reprostar 3 CAMAG 
Camera  HV-C20 Hitachi 
E. coli Pluser Biorad 
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2. Methods 
 
2.1 Cultivation of E. coli Cells 
A single colony was always inoculated to 3 ml of LB liquid medium or a LB agar plate and 
incubated at 37°C overnight for isolating plasmid DNA or detection of CCC plasmid size. For 
selection of correct clones, different antibiotics were added to media at the appropriate 
concentration. E. coli strain DH5α and strain ET12567 containing the RP4 derivative 
pUZ8002 served as hosts for routine subcloning and intergeneric conjugation, respectively. E. 
coli cells were concentrated by centrifugation and resuspended in 20% glycerol for 
preservation at –20°C. 
 
2.2 Growth and Preservation of Streptomyces Strains 
Streptomycetes were inoculated over the entire surface of the medium on agar in order to 
obtain confluent cultures. After 10-14 days growth, the grey hydrophobic spores were 
scraped from the surface of the plate and resuspended in 20% glycerol for preservation at –
20°C. To harvest high quality mycelium, spores were inoculated in liquid cultures and 
incubated for 36-40 hours at 30°C with vigorous shaking. 
 
2.3 Amplification of DNA Fragments by PCR 
Typical Polymerase Chain Reaction (PCR) was used for amplification of DNA fragment for 
cloning, expression or sequencing. Below is a list of reagents for the basic PCR system. 
                                                                 Forward primer (25 µM) – 1 µl 
             Reverse primer (25 µM) – 1 µl 
PCR buffer (10 ×) – 2 µl 
                                                                 dNTPs mix (10 mM for each) – 1 µl 
                                                                 BSA solution (10 mg/ml) – 1 µl 
                                                                 DMSO (100%) – 1 µl 
                                                                 Sterile purified water – 12 µl 
Template DNA (100-200 ng/µl) – 0.5 µl 
Taq DNA polymerase (5 units/µl) – 0.5 µl  
                                                                 Total reaction volume                       20 µl 
The nucleic acid sequences were amplified by the cycles of denaturation, annealing and 
polymerization. The details of PCR program were shown below. 
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1. Denaturation:                     94°C, 2 min 
2. Denaturation:                 94°C, 30 sec 
3. Primer annealing:           57°C, 30 sec     34 cycles 
4. Extension: 68°C,   1 min for 1 kb DNA 
5. Final extension:                  68°C, 4 min 
 
2.4 Purification of DNA Fragments from Solutions or Agarose Gel (Amersham) 
GFX PCR DNA and Gel Band Purification Kit (Amersham) can be used to purify DNA (e.g., 
PCR products, restriction fragments) from solution and from TAE and TBE agarose gel 
bands.  
For purification of DNA from gel bands, the gel slice containing the desired DNA fragment 
was weighted and treated with the same volume of capture buffer. For example, 300 mg of 
gel slice was afforded 300 µl of capture buffer. The mixture was incubated at 60°C until the 
agarose was completely dissolved. After brief centrifugation to collect the sample at the 
bottom of the tube, it was transferred to one GFX column in a collection tube. After 
centrifugation in a microcentrifuge at full speed for 30 seconds, the flow-through was 
discarded and the column was washed with 500 µl of wash buffer by centrifugation at full 
speed for 30 seconds. The GFX column was transferred to a fresh 1.5 ml microcentrifuge 
tube and DNA was eluted with 10-50 µl of purified water at room temperature for 1 min. 
Finally, purified DNA was recovered by centrifugation at full speed for 1 min. 
For purification of DNA from solution, the DNA solution (up to 100 µl) was mixed with 500 µl 
of capture buffer and transferred to the GFX column for centrifugation at full speed for 30 
seconds. The following procedures for washing and elution are the same as the above. 
  
2.5 Cloning of PCR Products with the pGEM-T Easy Vetor System (Promega) 
The pGEM-T Easy Vector was prepared by cutting with EcoRV and adding a 3’ terminal 
thymidine to both ends. These single 3’-T overhangs at the insertion site greatly improve the 
efficiency of ligation of a PCR product into the plasmid by providing a compatible overhang 
for PCR products generated by certain thermostable polymerases. The ligation reaction was 
set up as described below. 
                                                                 Rapid Ligation Buffer (2 ×) – 5 µl 
             pGEM-T Easy Vector (50 ng) – 1 µl 
PCR product (~200 ng/µl) – 3 µl 
T4 DNA Ligase (3 units/µl) – 1 µl 
Total volume                        10 µl 
The reaction was mixed by pipetting and incubated at room temperature for 1 hour or at 4°C 
overnight to get the maximum number of transformants. Half of the volume of the reaction 
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was used for transformation of competent E. coli cells and transformants were selected by 
blue/white screening. 40 µl X-gal (20mg/ml) and 40 µl IPTG (200mg/ml) solutions were 
spread on the agar plate containing appropriate antibiotics prior to the transformation. After 
incubation at 37°C for overnight, the desired clones which do not contain active β-
galactosidase due to the insertion of foreign DNA showed creamy-white, while the 
transformants only containing vectors were pale blue. 
 
2.6 Preparation High Quality Plasmid DNA from E. coli (Birnboim et al., 1979) 
1.5 ml of the overnight culture was decanted into an Eppendorf tube and spun in a benchtop 
centrifuge at 13,000 rpm for 1 min. After completely removing the supernatant, the cell pellet 
was carefully resuspended in 150 µl of solution I. 300 µl of freshly prepared solution II was 
added and the tube was inverted several times. Then 230 µl of precooled solution III was 
mixed into the reaction solution and inverted several times without vortexing. After 
centrifugation at 13,000 rpm for 10 min, the supernatant was removed to a clean tube and 80 
µl of neutral phenol/chloroform was added to remove proteins. After centrifugation, the 
aqueous supernatant was transferred into a new tube containing 800 µl of isopropanol, 
mixed by inversion and centrifuged for 10 min. The DNA pellet was washed in 70% ethanol, 
dried under reduced pressure and dissolved in 40 µl TE buffer. 
 
2.7 Introduction of DNA into E. coli 
2.7.1 Preparation and Transformation of Competent Cells by the Chemical 
Method 
A single colony was inoculated in 3 ml of LB medium for overnight shaking. On the next day, 
1 ml of the overnight culture was transferred into 100 ml of fresh LB broth and incubated at 
37˚C until the OD560 reached 0.4-0.5. E. coli cells were harvested by centrifugation at 5, 000 
rpm for 6 min at 4°C. The pellet was gently resuspended in 25 ml of ice-cooled TFBI buffer. 
After centrifugation at 5,000 rpm for 5 min at 4°C, cells were resuspended in 4 ml of TFBII 
buffer. Aliquots of 100 µl competent cells were dispensed into sterile Eppendorf tubes and 
stored at –80°C. Up to 20 µl DNA solution was added to one tube containing thawed 
competent cells.  After incubation in ice for ca. 20 min, cells were heat shocked at 37°C for 2 
min (or 42°C for 90 sec). The tube was cooled down in ice a little bit and added 0.9 ml of LB 
broth. After incubation at 37°C for about 1 hour, cells were spread on selective plates for 
incubation overnight at 37°C. 
 
2.7.2 Transformation of E. coli Cells by Electroporation (Chassy et al., 1988) 
A single colony of E coli was inoculated from a fresh agar plate into 50 ml of LB medium and 
cultured overnight at 37°C with vigorous aeration (200 rpm). 1000 ml of prewarmed LB 
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medium was inoculated with 25 ml of the overnight bacterial culture and incubated at 37°C 
with agitation until OD600 reached ~0.4. The culture was transferred to several ice-cold 
centrifuge tubes and cooled down on ice for 15-30 min. The cells were harvested by 
centrifugation at 2,500 rpm for 15 min at 4°C. The supernatants were decanted and the cell 
pellets were resuspended in 500 ml of ice-cold pure water. After centrifugation at 2,500 rpm 
for 20 min at 4°C, the cells were washed three times with 500 ml, 250 ml and 10 ml of ice-
cold 10% glycerol in turn. Cells were harvested by centrifugation at 2,500 rpm for 20 min at 
4°C and all liquid was carefully removed. Finally, the pellet was resuspended in 2 ml of ice-
cold 10% glycerol. Aliquots of 50 µl of the suspension were dispensed into sterile Eppendorf 
tubes and stored at –80°C. For transformation reaction, a volume of 1-2 µl DNA solution was 
added to 50 µl of the freshly thawed electrocompetent cells and mixed by pipette for several 
times. The mixture was transferred to the bottom of an ice-cold electroporation cuvette 
avoiding bubbles. The outside of the cuvette was dried with tissue before electroporation. A 
pulse of electricity was delivered to the cells at 25 µF capacitance, 2.5 kV and 200 Ohm 
resistance. As quickly as possible after the pulse, 1 ml of LB medium was added at room 
temperature and the mixture was transferred to a sterile Eppendorf tube and incubated with 
gentle rotation for 1 hour at 37°C. Different volumes of the culture were spread onto a LB 
agar plate containing appropriate antibiotic for selection of clones. 
 
2.8 Isolation of Genomic DNA from Streptomyces (Hopwood et al., 1985) 
Mycelium from a 25 ml culture was resuspended in the mixture of 4 ml of TE25S buffer and 
500 µl of 20 mg/ml lysozyme solution (final concentration of lysozyme is 2 mg/ml). The 
mixture in a 50 ml tube was incubated at 37˚C for 2-3 hours and turned several times in 
every 30 min until the suspension became milky. After adding 2 ml of 10% SDS, it was 
incubated for 30 min at 37˚C again and turned over tubes every 5 min until the suspension 
became clear. 3 ml phenol/chloroform was added, vortexed 30 seconds and centrifuged for 
10 min. The procedure of precipitation with phenol/chloroform was repeated when separation 
of proteins was not optimal. The upper phase was transferred with “wide mouth” tips into 15 
ml tubes containing 700 µl of 3 M unbuffered sodium acetate and 5 ml of isopropanol. The 
tube was gently swirled and DNA became visible. DNA was spooled onto a sealed Pasteur 
pipette and washed with 70% ethanol. The DNA pellet was dried on air and dissolved in 500 
µl TE at 55˚C for several hours or at 37˚C overnight. 
 
2.9 Plasmid DNA Isolation from Streptomyces (Kieser, 1984) 
Mycelium from a ~5 ml culture was resuspended in a total volume of ~500 µl TE25S buffer 
supplemented with 2 mg/ml lysozyme and 5 µg/ml pre-boiled RNase A, and incubated at 
37°C for 1 hour. 250 µl of 0.3 M alkaline SDS solution (0.3 M NaOH, 2% SDS) was added 
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and mixed immediately by vortexing (larger volumes are best mixed using a disposable 
syringe). Tubes were opened and incubated for 15 min at 70°C (or 30 min at 55°C for 
plasmids ≥ 20 kb). When the tubes were cooled down to < 37°C, 80 µl of acid 
phenol/chloroform was added. The mixture was emulsified by vortexing and centrifuged for 
10 min. The supernatant (ca. 700 µl) was transferred to a new centrifuge tube containing the 
same volume of isopropanol and 50 µl unbuffered 3 M sodium acetate, mixed and 
centrifuged 10 min; all liquid was removed by a pipette and the precipitate was washed with 
70% ethanol for 15 min. It was dried at room temperature and dissolved in appropriate 
volume of TE. 
 
2.10 Introduction of DNA into Streptomyces 
2.10.1 Protoplast Transformation of Streptomyces (Kieser et al., 2000) 
100 µl of spore suspension (1010 spores/ml) was inoculated in 50 ml of YEME medium 
supplemented with required growth factors and incubated at 30°C for 36-40 hours in an 
orbital incubator shaker (200 rpm). Mycelium was harvested by centrifugation at 3,000 rpm 
for 10 min and washed with 30 ml of 10.3% sucrose two times. The mycelium pellet was 
resuspended in 8 ml P buffer supplemented with 1 mg/ml lysozyme and incubated at 30 °C 
for 15-60 min. When the supernatant became turbid, the mycelium suspension was gently 
drawn in and out three times by a 5 ml pipette and incubated for a further 15 min. After 
adding 5 ml P buffer, the mixture was drawn in and out again to help the release of 
protoplasts from the mycelium. The protoplast solution was filtered through cotton wool and 
transferred to a new sterile tube. After gently centrifugating at 2,500 rpm for 7 min, the 
protoplast pellet was resuspended in 300-1000 ml P buffer. Aliquots of 50 µl protoplast 
suspension were dispensed into tubes and stored at -80°C. Each tube was used for one 
transformation reaction. 5 µl of DNA solution was added to 50 µl thawed protoplast solution 
and mixed immediately with 200 µl T buffer by pipetting up and down several times. The 
mixture was spread on one dried R5 plate and incubated at 30°C. After 14-20 hours, the 
plate was overlaid with 1 ml sterile purified water containing appropriate amount of selective 
antibiotics. Resistant colonies became visible after 3 days of incubation at 30°C. 
 
2.10.2 Intergeneric Transfer of Plasmids from E. coli to Streptomyces by 
Conjugation (Flett et al., 1997) 
The oriT-containing construct was introduced into the competent cells of E. coli 
ET12567/pUZ8002 and incubated on LB agar containing 25 µg/ml kanamycin (selection for 
pUZ8002), 25 µg/ml chloramphenicol (selection for the dam mutation), and appropriate 
antibiotics used to select for incoming plasmid only. A single colony of the transformant was 
inoculated into 3 ml LB medium containing antibiotics and grown overnight. Next day, 10 µl of 
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the overnight bacterial culture was transferred to 1 ml fresh LB plus antibiotics and grown at 
37°C until OD600 reached 0.4-0.6. At the same time, approximately 108 Streptomyces spores 
for each conjugation were suspended into 500 µl of TES buffer (0.05 M TES, pH 8.0) and 
heat shocked at 50°C for 10 min. After cooling down, 500 µl of double strength germination 
medium was added and the mixture was incubated at 37°C for 2-3 hours. 1 ml of the E coli 
cells was washed three times with fresh LB medium without any antibiotic and mixed with the 
spores after germination. After brief spin, most of the supernatant was poured off. The pellet 
was resuspended in the residual liquid and plated on suitable agar medium. After incubation 
at 30°C for 16-40 hours, the plate was overlaid with I ml water containing 1 mg nalidixic acid 
and appropriate plasmid selective antibiotics and continuously incubated at 30°C for 3-5 days 
until potential exconjugants grew up. 
 
2.11 Construction of Cosmid Library (EPICENTRE) 
2.11.1 Insert DNA Preparation and End-Repair Reaction 
35 µg of the high molecular weight DNA (~0.5 µg/µl) was randomly sheared to 30-45 kb 
molecules by Sau3AI partial digestion and then concentrated by precipitation. The sheared 
DNA was treated with End-Repair Enzyme Mix to generate blunt ends for cloning into the 
prepared pWEB vector. The volumes listed below are for one end-repair reaction.   
                                                                 End-Repair Buffer (10 ×) – 8 µl 
             dNTP Mix (2.5 mM) – 8 µl 
ATP (10 mM) – 8 µl 
                                                                 Sterile water – 22 µl 
Sheared insert DNA – 30 µl 
End-Repair Enzyme Mix – 4 µl  
                                                                 Total reaction volume        80 µl 
The reaction was at room temperature for 45 min. After adding gel loading buffer, it was 
incubated at 70˚C for 10 min to inactivate the End-Repair Enzyme Mix.  
 
2.11.2 Size Selection of Insert DNA 
A 1% low melting point (LMP) agarose gel in 1 × TAE buffer was prepared without ethidium 
bromide. Following completion of electrophoresis, the outer lanes of the gel containing the 
T7 DNA marker were cut off. The T7 marker lanes were stained with ethidium bromide and 
the DNA was visible with UV light. The position of the T7 DNA marker was marked by using 
a pipet tip. The gel was reassembled and a 2-4 mm wide gel slice was excised, which 
contained insert DNA migrating between the T7 DNA marker. It was transferred into a clean 
tube and stored at -20˚C.  
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2.11.3 In-Gel Ligation 
The 2-4 mm LMP gel slice was melted at 70˚C for 10-15 min, and then the tube was cooled 
to 45˚C immediately and incubated for 5 min. In a separate tube at room temperature, the 
following reagents were combined in the order listed and mixed thoroughly after each 
addition.  
Sterile water – 15.5 µl 
Fast-LinkTM Ligation Buffer (10 ×) – 5 µl 
ATP (10 mM) – 2.5 µl 
pWEB Vector – 1 µl 
Molten agarose – 25 µl 
                                                                 Fast-Link DNA Ligase – 1 µl 
Total reaction volume   50 µl 
The mixture was incubated at room temperature for 2 hours. Then the reaction was heated 
at 70˚C for 10 min to melt the gel mixture and to inactivate the Fast-Link Ligase. 1 µl (1U) of 
GELaseTM Agarose Gel-Digesting Enzyme Preparation was then added and mixed 
thoroughly (leaving the tube at 45˚C). The tube was kept at 45˚C for 15 min to digest the 
agarose, and then heated to 70˚C for 10 min to inactivate the GELase enzyme.   
 
2.11.4 In Vitro Packaging 
The day before performing the packaging reactions, a single colony of EPI100 cells was 
inoculated into 50 ml of LB broth supplemented with 10 mM MgSO4 and shaken overnight at 
37˚C. In the next day, 5 ml of the overnight culture was transferred into 50 ml of 
supplemented fresh LB broth and shaken at 37˚C until the OD600 reached 0.8-1.0. The cells 
could be stored at 4˚C up to 72 hours.  
10 µl of the ligated cosmid DNA was pipetted into a tube containing 25 µl of thawed 
packaging extract and incubated at 30˚C for 90 min. At the end of the incubation, an 
additional 25 µl of thawed extract was added to the mixture at 30˚C for an additional 90 min. 
Subsequently, 500 µl of phage dilution buffer (10 mM Tris-HCl (pH 8.3), 100 mM NaCl, 10 
mM MgCl2) and 25 µl of chloroform were added and mixed by gentle vortexing. 
To determine the titer of the packaged cosmids, 10 µl of the packaged cosmids was added 
to 100 µl of prepared EPI100 host cells at room temperature for 20 min and spread on LB-
ampicillin selection plates at 37˚C overnight. Count colonies and calculate the titer.    
(# of colonies) (dilution factor) (1000 µl/ml)   = (600 cfu) (1) (1000 µl/ml) = 6 × 104 cfu/ml 
      (volume of phage plated (µl))                                     (10 µl) 
The total number of clones that could be obtained with the cosmid library was calculated by 
multiplying the titer (cfu/ml). The number of clones required to ensure that any given DNA 
sequence will be found in the cosmid library varies with the size of the genome.  
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N = ln (1-P) / ln (1-f ) 
Where P is the desired probability (expressed as a fraction); f is the proportion of the 
genome contained in a single clone; and N is the required number of cosmid clones. For 
example, the number of clones required to ensure a 99.9% probability of a given DNA 
sequence of Streptomyces is contained within a cosmid library composed of 40 kb inserts is: 
N = ln (1-0.999) / ln (1- (4 × 104 bases / 8 × 106)) = -9.21/ -0.005 = 1842 clones 
Finally, a sufficient number of clones were inoculated into 22 ninety-six-well plates with 100 
µl of LB medium containing ampicillin. After shaking at 37˚C overnight, 100 µl of 40% 
glycerol was added to the 100 µl culture of each clone for stored at -80˚C.  
 
2.12 Construction of a Random Shotgun Library for Sequencing 
2.12.1 Random Incision of Cosmid DNA by Sonication 
~8 µg cosmid DNA was dissolved in 400 µl of sterile purified water and aliquots of 100 µl 
cosmid DNA solution were dispensed into 1.5 ml Eppendorf microcentrifuge tubes. First 
three tubes of sample DNA were used to find the suitable setting conditions of the sonicator 
(Bandelin). Sizes of sheared DNA fragments were monitored by electrophoresis. When most 
of the DNA fragments ranged between 0.5-3 kb range, the setting (50% energy, 60% cycle, 
10 seconds) was used again for the fourth tube of the DNA sample.  
 
2.12.2 Blunt End-Repair Reaction 
Four tubes of sheared DNA solution were mixed together and precipitated with 40 µl of 3 M 
sodium acetate (pH 5.2) and 800 µl of ethanol. The pellet was dissolved in 30 µl sterile 
purified water and treated with End-Repair Enyzyme Mix (EPICENTRE) to generate blunt 
ends. The following solutions were combined in the order listed and mixed thoroughly. 
                                                                 End-Repair Buffer (10 ×) – 8 µl 
             dNTP Mix (2.5 mM) – 8 µl 
ATP (10 mM) – 8 µl 
                                                                 Sterile water – 22 µl 
Sheared insert DNA – 30 µl 
End-Repair Enzyme Mix – 4 µl  
                                                                 Total reaction volume        80 µl 
The reaction was incubated at room temperature for 1 hour. After adding gel loading buffer, 
the mixture was incubated at 70˚C for 10 min to inactivate the End-Repair Enzyme Mix. 
 
2.12.3 Size Selection of Sheared DNA Fragments 
Different sizes of sheared DNA were separated by electrophoresis with a 0.8% agarose gel 
in 1 x TAE buffer without ethidium bromide. After completion of electrophoresis, the agarose 
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gel was stained with fresh 1% ethidium bromide solution for half an hour until the DNA was 
visible under UV light. 1.0-1.5 kb fragments were excised with a 2-4 mm wide gel slice and 
recovered from agarose gel by the GFX PCR DNA and Gel Band Purification Kit 
(Amersham).  
 
2.12.4 Ligation with Sequencing Vector DNA 
The sequencing vector pBluescript SK (-) was prepared in advance by digestion with EcoRV 
and dephosphatization with SAP. The ligation system was established by mixing the 
following reagents at 4˚C. 
                                                                 T4 DNA Ligation Buffer (10 ×) – 2 µl 
             pBluescript SK (-)/EcoRV/SAP (~100 ng) – 1 µl 
                                                                 Sterile water – 6 µl 
Sheared insert DNA (~400 ng) – 10 µl 
T4 DNA Ligase – 1 µl                      
                                                                 Total reaction volume 20 µl 
The reaction was incubated at 14˚C for 12-16 hours. 
 
2.12.5 Transformation of E. coli Cells 
Aliquots of 2.5 µl ligation product were introduced into E. coli DH5α competent cells and the 
transformants were spread on LB agar plates overlaid with 50 µl of 20 mg/ml IPTG and 50 µl 
of 20 mg/ml X-gal. After incubation at 37˚C for overnight, only white colonies were selected 
to check the size of plasmids. 
 
2.13 Southern Hybridization 
2.13.1 Capillary Transfer and Fixation of DNA (Sambrook et al., 2001) 
After completion of electrophoresis, the agarose gel containing DNA samples was stained 
with ethidium bromide and photographed. The gel was immersed in 0.25 M HCl solution for 2 
× 15 min at room temperature with constant gentle agitation until bromophenol blue indicator 
turned yellow. After washing the gel with purified water for several seconds, it was soaked in 
denaturation solution for 2 × 15 min with gentle agitation. Then the gel was briefly rinsed in 
purified water and soaked in neutralization buffer for 2 × 20 min with gentle agitation. Just 
before transfer, the gel was soaked in transfer buffer (10× –20× SSC) for several minutes 
with gentle agitation. A nylon membrane (Hybond-N+, Amersham) was cut ~1 mm larger 
than the gel in each dimension. Two sheets of thick blotting paper were also cut to the same 
size as the membrane. The membrane was floated on the surface of a dish of purified water 
until it wetted completely from beneath, and then immersed in 2 × SSC for at least 5 min 
before use. The following items were put on a smooth, flat surface in the order listed: 
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A 3 mm Whatman paper saturated with transfer buffer 
Nylon membrane prewet and saturated with transfer buffer 
3 piece of 3 mm Whatman paper saturated with transfer buffer 
Paper towels 
A light weight to keep all layers compressed. 
The gel was surrounded with plastic wrap or parafilm to prevent the two layers of gel blot 
paper from coming in contact with each other. The transfer of DNA usually proceeded within 
8-24 hours. The DNA was fixed to the membrane by UV-crosslinking (2 min, 120,000 
microjoules per cm2). 
 
2.13.2 Labeling of the Probes (DIG DNA Labeling and Detection Kit, Roche 
Molecular Biochemicals) 
DNA was labeled with Digoxigenin-11-dUTP using a mixture of random hexamers, a dNTP 
mix containing alkali-labile Digoxigenin-11-dUTP and labeling grade Klenow enzyme 
according to the manufacture’s manual. 10 ng-3 µg DNA was denatured at 99°C for 10 min 
and quickly chilled into ice. In ice, the followings were mixed and centrifuged briefly. 
                                                                 Freshly denatured probe DNA – 15 µl 
                                                                 Hexanucleotide Mix (10 ×) – 2 µl  
dNTP Labeling Mix  – 2 µl 
                                                                 Klenow enzyme labeling grade – 2 µl 
The reaction was incubated at 37°C for up to 20 hours and stopped by adding 2 µl of 0.2 M 
EDTA (pH 8.0) and/or by heating to 65°C for 10 min.  
 
2.13.3 Hybridization (DIG DNA Labeling and Detection Kit, Roche Molecular 
Biochemicals) 
The membrane was prehybridized at 65-68°C for several hours in 20 ml hybridization buffer 
per 100 cm2 membrane with gentle agitation. Before hybridization, DIG-labeled DNA probe 
was denatured at 99°C for 10 min and rapidly cooled on ice. The denatured DIG-labeled 
DNA probe was mixed with pre-heated hybridization buffer (3.5 ml/100 cm2 membrane) 
avoiding bubbles, which may lead to background signals. The old prehybridization solution 
was exchanged for the probe/hybridization mixture. The membrane was incubated with this 
mixture at least 6 hours to overnight with gentle agitation at 65-68°C. 
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2.13.4 Immunological Detection (DIG DNA Labeling and Detection Kit, Roche 
Molecular Biochemicals) 
For stringency washes, the membrane was briefly rinsed in ample 2 × SSC, 0.1% SDS for 2 
× 5min at 15-25°C under constant agitation and then in 0.5 × SSC, 0.1% SDS (prewarmed to 
wash temperature) at 65-68°C for 2 ×15min under constant agitation. 
After hybridization and stringency washes, the membrane was briefly rinsed for 1-5 min in 
washing buffer and then incubated for 30 min in 100 ml blocking solution at room 
temperature. After pouring off the blocking solution, the membrane was incubated again for 
30 min in 20 ml antibody solution. After washing with 100 ml washing buffer for 2 × 15min, it 
was equilibrated in 20 ml detection buffer for 2-5min and then incubated in 10 ml freshly 
prepared colorsubstrate solution in the dark. When the desired spot or band intensities were 
achieved, the color reaction was stopped by washing the membrane for 5 min with 50 ml 
ddH2O or TE. The results were documented by photocopying the wet filter or by photography. 
 
2.14 Screening the Genomic Cosmid Library by PCR 
20 µl of cell suspension from each well in the same vertical row was taken out and mixed 
together to form a row pool. In one ninety-six-well plate, 12 row pools were built up and the 
plate pool was composed of 16 µl of cell suspension from each of these row pools. For the S. 
thioluteus genomic library, 22 plate pools from 22 ninety-six-well plates were centrifuged at 
13,000 rpm for 2 min. Every cell pellet was washed with purified water twice and then 
resuspended in 96 µl purified water for use in a PCR reaction with the Triple Master Mix Kit 
(Eppendorf).  
Master-Mix 1: 
                                                                 Forward primer (25 µM) – 4.4 µl 
             Reverse primer (25 µM) – 4.4 µl 
                                                                 PCR Buffer HiFi (10 ×) – 11 µl 
                                                                 DMSO (100%) – 13.8 µl 
                                                                 Purified water – 48.9 µl 
                                                                 Total volume      82.5 µl 
For 20 µl of PCR reaction system, aliquots of 6 µl Master-Mix 1 were put into one 500 µl 
PCR-tube and mixed with 2 µl of template DNA. The mixture was incubated at 98°C for 1 min 
and then cooled down on ice.  
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Master-Mix 2: 
                                                                 PCR Buffer HiFi (10 ×) – 16.5 µl 
                                                                 dNTP Mix (10 mM) – 5.5 µl 
                                                                 Purified water – 141.4 µl 
                                                                 Triple Mastermix Polymerase – 1.6 µl 
                                                                 Total volume                             165 µl 
After 12 µl of Master-Mix 2 was added to each PCR system, PCR-tubes were immediately 
transferred to the preheated (94°C) PCR machine to start the programme. 
If PCR result was positive in some plate, 12 row pools of this plate were used as templates 
for PCR screening again. The same strategy was also performed for positive row pools until 
all positive colonies were detected. The ketosynthase (KS)-specific degenerate primers 
KSF1 and KSR1 were used to screen the whole library first. One pair of degenerate primers 
PABAF1 and PABAR1 was used for detection of the presence of pabAB homologs in all KS-
positive colonies. 
 
2.15 Gene Knock-out by PCR Targeting System (Plant Bioscience Limited) 
For each gene disruption, two long PCR primers (58 nt and 59 nt) were designed according 
to the sequence of the target gene and the antibiotic resistance cassette. Each of the two 
primers has at the 5’ end 39 nt matching the flanking sequence of target gene, and a 3’ 
sequence (19 nt or 20 nt) matching the right or left end of the antibiotic resistance cassette. 
With these two long primers, the antibiotic resistance cassette (e.g. streptomycin and 
spectinomycin resistance gene, aadA) flanked by FRT sites (FLP recognition targets) was 
amplified by PCR. After introducing the PCR product into E. coli BW25113/pIJ790 (λ Red 
recombination plasmid) containing the cosmid by electroporation, the target gene was 
replaced by the extended antibiotic resistance cassette. In the other host strain E. coli 
DH5α/BT340 (temperature sensitive FLP recombination plasmid), the resistance cassette 
was removed through expression of the FLP-recombinase, yielding an in-frame deletion 
mutant. The detailed procedures for experiments are described in the manual of the PCR 
targeting system (Plant Bioscience Limited). 
 
2.16 Feeding Experiments 
50 ml of YEME medium was inoculated with 100 µl Streptomyces spore suspension (1010 
spores/ml) and incubated at 30°C for 36-40 hours with shaking. 5 ml of the culture was 
transferred into 100 ml of fresh M10 medium and continuously incubated at 30°C. After 2 
days of growing, when the mycelium became abundant, the culture was fed with different 
substances dissolved in DMSO or the mixture of DMSO and H2O and incubated for another 5 
days on a rotary shaker. 
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2.17 N-Oxidation Assay 
The mycelium was harvested by filtration at an early stage (2 days) of the growth (3-5 mg 
dry weight of cells per millilitre of the culture medium) and washed with 0.85% sodium 
chloride solution twice. The washed cells (2 g dry weight) were resuspended in 100 ml of 
phosphate-buffered saline (PBS) containing 50 µmol of sodium p-aminobenzoate. The 
mixture was incubated at 30°C with reciprocal shaking for about 6 -12 hours. 10 ml of 
aliquots of the reaction mixture were filtered to remove cells, acidified with 0.5 ml of 1 M HCl, 
and extracted with ethylether. The concentrated ether extracts were applied to TLC with 
chloroform-methanol mixture (9:1).  
 
2.18 Fermentation and Detection of Metabolites 
Aureothin and derivatives were extracted from chopped agar plates or from liquid culture 
broths of wild-type and recombinant strains with 50 ml ethyl acetate. Extracts were 
concentrated under reduced pressure and redissolved in 500 µl MeOH. Compounds were 
analyzed and identified by thin-layer chromatography (TLC), high-performance liquid 
chromatography (HPLC), mass spectrometry (MS) and nuclear magnetic resonance (NMR). 
HPLC analysis was carried out on a KROMASIL C15 column (Jasco) eluted with 
methanol/water (75:25) in 20 min at a flow rate of 0.8 ml/min and UV detection at 345nm. 
ESI-CID-MSn was recorded on a Finnigan LCQ benchtop mass spectrometer equipped with 
an electrospray ion source and ion-trap mass analyzer (negative mode). 
For large scale fermentation, Streptomyces strains were grown with orbital shaking at 30°C 
in M10 medium supplemented with selective antibiotic. 500 ml of 3 days old seed culture was 
inoculated in 20 l of fermentation medium in a stainless steel fermenter. After 5 days with 
constant stirring at 30°C, the broth was centrifuged for separation of the biomass from the 
liquid. Both mycelium and supernatant were extracted five times with 250 ml ethyl acetate for 
at least one hour.  
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C. Results and Discussion 
1. Cloning, Sequencing and Heterologous Expression of the 
Aureothin Biosynthesis Gene Cluster 
 
1.1 Design of the Primers for Cloning 
The structure and incorporation pattern of aureothin suggested the involvement of a type I 
PKS in the biosynthesis of the polyketide moiety. Because of the high similarities of genes 
encoding isoenzymes, amplification of gene fragments by PCR with conserved degenerate 
primers has become the preferred method for confirmation the presence of desired genes. 
Therefore, two ketosynthase (KS)-specific primers KSF1 and KSR1 (Beyer et al., 1999) were 
first employed to amplify KS homologous regions in the genome of the aureothin producer, S. 
thioluteus HKI-227. From the PCR product, the expected 700 bp fragments (Fig.3.2D) were 
separated from some weak unspecifically amplified fragments of different sizes by 
electrophoresis and cloned into the pGEM-T Easy Vector for sequencing. Sequence analysis 
of five single colonies revealed several DNA sequences with high homology to KS genes of 
modular type I PKS.  
In many cases, Streptomyces genomes do not only bear one, but several type I PKS gene 
clusters (Sun et al., 2002 and Ikeda et al., 2003). In order to target the aureothin (aur) 
biosynthesis gene cluster, several pairs of conserved degenerate primers (Fig.3.1) were also 
designed for complementary amplification of PABA synthase gene homologs from the S. 
thioluteus genome, one of which may play a key role for aureothin biosynthesis. In primary 
metabolism, PABA is synthesized from chorismate via 4-amino-4-deoxychorismate by the 
successive action of two individual PABA synthase subunits, PabA and PabB. Conversely, 
both subunits of PABA synthases from eukaryotes and bacterial secondary metabolism are 
covalently linked into one translational unit (Campelo et al., 2002 and Chen et al., 2003). 
Using total DNA of S. thioluteus as template, several PCR products were obtained by PCR 
with different pairs of primers. By BLAST database searches, two copies of PABA synthase 
genes were detected in different PCR products. A ca. 300 bp PCR product (Fig.3.2C) 
showed homology to pabA from primary metabolism, while the other ca. 1 kb fragment 
(Fig.3.2B) had high similarity with the pabAB gene of the polyene macrolide candicidin gene 
cluster (Criado et al., 1993 and Campelo et al., 2002). Therefore, the bigger fragment of the 
pabAB homolog was used as the second probe for identification of the aur gene cluster.  
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Figure 3.1. Amino acid sequence alignment of some known p-aminobenzoate synthases from S. 
venezuelae (Brown et al., 1996), S. pristinaespiralis (Blanc et al., 1997) and S. griseus (Campelo 
et al., 2002). Only several conserved regions used for design of the degenerate primers are shown. 
    
Figure 3.2. Analysis of the PCR products with KS-specific primers and two different pairs of 
PABA synthase-specific primers, respectively. Lanes A and E contain 1 kb ladder and 100 bp 
ladder as size standards. Lanes B and C display two PCR products obtained with two different pairs of 
PABA-specific primers, PABAF1 and PABAR1, PABAF2 and PABAR2, respectively; on lane D the 
PCR product obtained with KS-specific primers, KSF1 and KSR1, is visible. 
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1.2 Construction and Screening of a S. thioluteus HKI-227 Genomic Cosmid 
Library 
In order to clone the aureothin biosynthesis gene cluster, genomic DNA of S. thioluteus HKI-
227 was used for construction of a cosmid library. The genomic DNA was partially digested 
with Sau3AI, size-fractionated by gel electrophoresis, yielding fragments with an average 
size of approximately 40 kb, and blunted using the end-repair mix. After size selection by 
electrophoresis, the approximate 40 kb DNA fragments were ligated into the supplied blunt-
ended pWEB cosmid vector, packaged with lambda packaging extracts and infected the E. 
coli EPI100TM cells (Epicentre) to get enough cosmids for the library. After random detection 
for the insert size of 10 single colonies, 2112 cosmid clones were inoculated into 22 ninety-
six-well plates for preservation of the library at –80°C. The cosmid library was first screened 
for type I PKS genes by a PCR based approach using one pair of degenerate 
oligonucleotides, the ketosynthase (KS)-specific primers, KSF1 and KSR1. The PCR product 
from total DNA was used as DIG-labeled probe for Southern hybridization to confirm the 
results of screening with PCR. Cosmid mapping, PCR and hybridization experiments 
revealed the presence of several type I PKS gene clusters in the S. thioluteus genome 
(Fig.3.3 and 3.4). 
 
 
 
Figure 3.3. Restriction analysis of the positive cosmids obtained by PCR based screening 
method with KS-specific primers, KSF1 and KSR1. The last lane contains 1 kb ladder as size 
marker, while the other Lanes display the DNA samples of most KS positive cosmids digested with 
BamHI. 
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Figure 3.4. Cosmid mapping of pST18E4 and its overlapping cosmids, pST19C5 and pST18C7.  
 
Successively, the PABA synthase (pabAB)-specific primers, PABAF1 and PABAR1, based 
on universally conserved PABA synthase motifs, were used for the complementary screening 
on a smaller scale of KS positive clones to fish out the putative aur genes cluster out of the 
various S. thioluteus type I gene clusters. The PCR product from the genomic DNA was also 
employed for Southern hybridization. Out of 31 KS positive clones obtained by PCR, only 
one cosmid, pST18E4, was positive to both of the KS and pabAB gene probes by either PCR 
or hybridization (Fig.3.5). 
 
Figure 3.5. Southern hybridization results of cosmid pST18E4 DNA using KS and pabAB gene 
probes. B and C are the color-developed Nylon membranes of Southern transfer of the agarose gel 
(A) using Dig-dUTP-labeled KS and pabAB genes probes, respectively. The DNA sample of pST18E4 
(lane 2 in A) was digested with BamHI. Out of all pST18E4 BamHI-digested products, four fragments 
of 2.4 kb, 3.7 kb, 4.5 kb and 7.3 kb, showed apparently positive to KS probe (B), while only the 3.4 kb 
fragment gave the positive signal to pabAB probe (C). Lane 1 in A contains a sample of 1 kb ladder as 
size marker. 
pST18C7
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PABAS 
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1.3 Heterologous Expression of the Aureothin Biosynthesis Gene Cluster 
To date two general methods are usually employed to verify the functions of cloned gene 
clusters. One is to inactivate of some important genes in the cluster and this strategy is also 
usually used to affirm the two boundaries of the gene cluster. The other is to express the 
entire gene clusters or some functional regions in relational heterologous hosts that are 
lacking a similar biosynthetic pathway. In order to verify the identity of the aureothin gene 
cluster by inactivation, various attempts to introduce foreign DNA into S. thioluteus HKI-227 
have been undertaken, which all failed. Therefore, heterologous expression of the putative 
gene cluster was attempted. A ca. 40 kb SspI fragment of cosmid pST18E4, which harbors 
PKS genes as well as the PABA synthase gene, was recovered including the pWEB cos site 
and ligated into the EcoRV site of the integrative E. coli - Streptomyces shuttle vector 
pSET152. The resulting cosmid pHJ11 (Fig.3.6) was phage packaged and used for 
transfection of E. coli EPI 100. Restriction mapping proved that the new construct contained 
all desired fragments as expected. By protoplast transformation, pHJ11 was introduced into 
S. lividans ZX1, and the resulting transformant (S. lividans ZX1:pHJ11) was cultivated for five 
days. After extraction, HPLC and ESI-MS analyses unequivocally showed that aureothin is 
produced by the transformant at a titer comparable with the wild-type (Fig.3.7).  
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Figure 3.6. Construction of pHJ11 and pHJ48 for heterologous expression of the aur gene 
cluster. Ca. 40 kb SspI fragment was cut out from pST18E4 and ligated with the blunt ends of shuttle 
vector pSET152 DNA generated by EcoRV digestion to yield the resulting construct pHJ11. For 
researching the boundaries of the aureothin biosynthesis gene cluster, the 29.8 kb EcoRV fragment 
from pST18E4 was inserted into the EcoRV site of vector pSET152 to give the subclone pHJ48 for 
heterologous expression in S. lividans ZX1. 
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Since the cloned genes were sufficient to confer on S. lividans ZX1 the ability to produce 
aureothin, the cosmid insert of pST18E4 was subjected to both directed and shotgun 
subcloning and sequencing. 
aureothin
5 10 15 min
S. lividans ZX1
S. thioluteus HKI-227
S. lividans ZX1::pHJ48
 
 
Figure 3.7. HPLC analysis of extracts from the wild-type strain S. thioluteus HKI-227, host S. 
lividans ZX1, and transformant S. lividans ZX1::pHJ48. The HPLC work was performed by a 
colleague, Markus Müller. 
 
1.4 Sequence Analysis of the Genomic Region Involved in Aureothin 
biosynthesis 
Cosmid pST18E4 was sonicated, end-repaired by the End-Repair Enzyme Mix (Epicentre), 
and size-fractionated by agarose gel electrophoresis. Ca. 2 kb DNA fragments were cloned 
into pBluescript II SK(-) digested by EcoRV and end sequenced. Remaining gaps were filled 
by targeted subcloning and primer walking until completion of the sequence assembly for the 
whole cosmid. The nucleotide sequence (GenBank accession nr. AJ575648) was analyzed 
for open reading frames (ORFs) by the FRAME program (Bibb et al., 1984). The boundaries 
of the aureothin gene cluster were determined by subcloning a 30 kb EcoRV fragment of 
pST18E4 into pSET152, yielding the integrative expression plasmid pHJ48 (Fig.3.6). This 
surprisingly small fragment proved to be sufficient for aureothin biosynthesis by heterologous 
expression in S. lividans ZX1 (Fig.3.7). The deduced gene organization of the gene cluster is 
graphically presented in Fig.3.8 and the results of the sequence analyses are summarized in 
Table 3.1.  
Putative functions of deduced gene products were assigned based on homologies with 
known protein sequences in the databases (BLAST and PROSITE searches). Nine genes 
involved in aureothin biosynthesis were identified and designated aurA through aurI. In the 
aur operon, all genes are transcribed in one direction except for aurE, which is convergently 
transcribed. Aureothin biosynthesis is probably regulated by the predicted 271 aa gene 
product of aurD, which has 34% identity with AfsR (Horinouchi et al., 1990), a global 
regulatory protein for secondary metabolite formation in S. coelicolor A3(2). Downstream of 
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the aur biosynthetic gene cluster, a gene (aurJ) encoding a transposase was located. 
Interestingly, no candidate genes for resistance have been detected. 
 
1.4.1 The Aureothin PKS Genes 
In the 27 kb region encoding aur biosynthesis, three large ORFs, aurA-C, encoding a 
bacterial type I PKS, were identified. Functional features of the deduced 1906 aa, 2164 aa 
and 2201 aa gene products were determined by comparing them with known type I PKS 
systems and detection of signature motifs of the domains. The aureothin PKS shows some 
unusual characteristics with regard to PKS initiation and termination and, most remarkably, in 
chain elongation.  
A aurD E F C G H B I
2 kb  
Figure 3.8. Organization of the aureothin biosynthetic gene cluster in S. thioluteus HKI-227. 
Each arrow indicates the direction of transcription and relative sizes of the ORFs deduced from 
analysis of the nucleotide sequence. White ORFs, type I PKS genes; black ORFs, genes putatively 
involved in starter unit biosynthesis; checked ORFs, genes encoding tailoring enzymes; hatched ORF, 
regulator gene. 
 
Table 3.1. Deduced functions of ORFs in the aureothin biosynthetic gene cluster 
Protein 
Amino 
Acids 
Proposed Function 
Sequence Similarity  
(Protein, Origin) 
Identity/ 
Similarity, 
% 
Protein 
Accession 
Number 
Reference 
AurD 271 Transcriptional 
activator 
AfsR, Streptomyces coelicolor 34/45 BAA14186 Horinouchi et 
al., 1990 
AurE 505 Acyl-CoA ligase Feruloyl-CoA synthetase, 
Amycolatopsis sp. HR167  
34/50 AX172316  
AurF 481 Amine oxidase none none   
AurA 1906 Polyketide synthase AVES 2, Streptomyces avermitilis 45/56 BAA84475 Ikeda et al.,  
   Module 1  KS AT DH KR ACP    1999 
AurG 695 PABA synthase PabAB, Streptomyces griseus 44/53 CAC22117 Campelo et 
al., 2002 
AurH 406 Cyt P-450 
hydroxylase 
Cytochrome P-450, 
Mycobacterium smegmatis  
36/51 AF102510 Poupin et al., 
1999 
AurB 2164 Polyketide synthase NysC, Streptomyces noursei 48/59 AAF71776 Brautaset et 
  Module 2  KS  AT  ER  DH  KR  
ACP 
   al., 2000 
AurC 2201 Polyketide synthase AVES 4, Streptomyces avermitilis 45/60 BAA84479 Ikeda et al.,  
  Module 3  KS  AT  ACP    1999 
  Module 4  KS  AT  ACP  TE     
AurI 230 O-Methyltransferase EncK, Streptomyces maritimus 36/54 AAF81726 Piel et al., 
2000 
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Analysis of AurA reveals a monomodular protein that is assumed to catalyze the first steps in 
polyketide assembly. The module harbors KS, AT and ACP domains, as well as two keto 
processing domains (KR and DH). The module arrangement corresponds with unsaturated 
acyl intermediates, which are in fact the proposed products after the first and second 
elongation steps. Leadlay and coworkers have reported sequence differences between 
methylmalonate and malonate specific acyl transferases, which allow the prediction of AT 
substrate specificity (Haydock et al., 1995 and Aparicio et al., 1996). In accord with the 
structure of aureothin, the AT1 signature motif indicates specificity for methylmalonyl-CoA. At 
its N-terminus, AurA shows only very low homology to an ACP domain and the common ACP 
signature motif (GxDS) is absent, as reconfirmed by repeated sequencing of this region.  
AurB is a monomodular enzyme consisting of KS, AT and ACP domains and an additional 
set of KR, DH and ER, which is capable of performing a full reductive cycle. The module 
composition and the presence of a malonate-specific AT domain provide strong evidence 
that this module is involved in the third round of elongation and reduction.  
AurC represents a bimodular protein with a thioesterase (TE) domain located at the C-
terminus. The TE domain contains characteristic GxSxG and GxH motifs and has high 
homology to various authentic TE domains from type I PKS. Consequently, the two PKS 
modules encoded by aurC would catalyze the last two Claisen condensations. In agreement 
with this assumption, each module of AurC is composed of KS, AT and ACP domains only, 
leaving the β-keto group unreduced. Upon release from the PKS, the resultant β,δ-diketo 
acid would cyclize – either spontaneously or catalyzed by the TE – to yield the corresponding 
pyrone moiety. It is noteworthy that in bacteria similar chemistry is only known from 
polyketides generated from natural and mutant type II PKS rather than type I PKS (Piel et al., 
2000). 
In modules 1 to 4, all the PKS domains show typical conserved signature motifs except AT4 
(Table 3.2). In contrast to ATs 1-3, which exhibit the GHSxG active site and (methyl)malonyl-
CoA specificity motifs, AT4 shows only weak sequence identity to known AT domains, and 
both the active site and specificity motifs are aberrant. As confirmed by resequencing the 
AT4 domain with specific primers and the expression cosmid as template, in the typical 
GHSxG motif, histidine is mutated to arginine and serine is mutated to alanine. The presence 
of a GRADG motif most likely results in loss of acyltransferase activity. Recently, anomalous 
and possibly inactive AT domains have also been reported for the pyoluteorin PKS (Nowak-
Thompson et al., 1997). 
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Table 3.2. Analysis of the active site and substrate specificity motifs of the aur PKS AT1-4 
domains.  
 
AT Active site motif Specificity motif Substrate 
AT1 PAAVVGHSQGEIAA RVDVV Methylmalonyl-CoA 
AT2 PDLLLG HSIGELTA QTGYT Malonyl-CoA 
AT3 PGAVVGHSQGEIAA RVDVV Methylmalonyl-CoA 
AT4 PAFVHGRADGEVAA None Inactive ? 
 
In summary, the aur biosynthesis gene cluster encodes two monomodular and one 
bimodular proteins, which assemble to a tetramodular megasynthase (Fig.3.9). The domain 
arrangement of modules 2-4 corresponds perfectly to the degree of reduction of the furane 
and pyrone moieties of aureothin. However, while the architecture of AurA logically accounts 
for double bond formation, it appears that only one module catalyzes two successive rounds 
of elongation before transfer of the polyketide chain to module 2. Such an iterative chain 
elongation would be in clear contrast to the proposed and generally accepted one-to-one 
correspondence between encoded modularity of the enzyme activities and structure of the 
resultant products. 
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Figure 3.9. Domain architecture of the aureothin polyketide synthase. 
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1.4.2 Genes Putative Involved in Starter Unit Synthesis and Post-PKS 
Processing 
Besides three large ORFs encoding a type I PKS (aurA-C), genes putatively involved in 
starter unit biosynthesis and post-PKS reactions were detected. By PCR and hybridization 
experiments, it has been shown that a homolog of pabAB, a gene encoding a PABA 
synthase in S. griseus (Criado et al., 1993), is located on the aureothin gene cluster. The 
deduced 695 amino acid gene product of aurG has high homology to a group of bifunctional 
PABA synthases, which are typical for eukaryotes (Edman et al., 1993) but have also been 
implicated in the secondary metabolism of a few Streptomyces species (Criado et al., 1993 
and Brown et al., 1996 and Blanc et al., 1997). In general, PABA synthases are known to 
catalyze the conversion of chorismic acid to p-aminobenzoic acid by transamination and 
subsequent hydrolysis (Green et al., 1991). In contrast to the monofunctional enzymes PabA 
and PabB involved in bacterial folate biosynthesis, the putative aur PABA synthase 
possesses two linked catalytic domains, which are functionally equivalent to PabA and PabB. 
Homologues of AurG have been found to be involved in the biosynthesis of the polyene 
macrolides candicidin and FR-008 (Chen et al., 2003).  
ORF aurE presumably encodes an acyl CoA ligase. The deduced 505 aa gene product 
contains an AMP-binding site and has significant sequence homology to a number of acyl-
CoA ligases, such as feruloyl-CoA synthetase from Amycolatopsis sp. HR167 (35% identity 
over 470 amino acids, GenBank accession number AX172316). In analogy to a variety of 
other unusual starter units (Moore et al., 2002), the aur PKS primer is probably activated as 
the corresponding CoA thioester by AurE. 
In the deduced gene product of aurI, an ORF located downstream of the PKS genes, a 
probable S-adenosyl methionine-binding motif was identified (PRO-SITE: PS50193) that is 
characteristic for methyltransferases. Strikingly, AurI shows highest homology (36% identity 
over 209 amino acids) to EncK from “Streptomyces maritimus”, which functions as a pyrone 
O-methyl transferase in enterocin biosynthesis (Piel et al., 2000 and Xiang et al., 2002). In 
analogy, AurI is assumed to be responsible for the introduction of the pyrone O-methyl group.  
A putative cytochrome P-450 oxygenase encoding gene is located downstream of the PABA 
synthase gene aurD on the aureothin gene cluster, designated aurH. The proposed 406 aa 
gene product has highest homology to a hydroxylase from Mycobacterium smegmatis, which 
is required for piperidine and pyrrolidine utilization (Poupin et al., 1999). Two homologous P-
450 oxidase representatives involved in polyketide tailoring reactions are the 6-
deoxyerythronolide B hydroxylase EryF from Saccharopolyspora erythraea (Weber et al., 
1991), and AveE from S. avermitilis, which has been shown to play a role in avermectin 
biosynthesis (Ikeda et al., 1999). This strongly suggests that AurH is implicated in furan ring 
formation. 
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Strikingly, the deduced amino acid sequence of the remarkably arginine rich 336 aa gene 
product of aurF has no homology to all known active sites (PROSITE) in databases.  
 
1.5 Discussion 
By screening the cosmid library with two special probes, genes involved in the biosynthesis 
of aureothin, a rare nitroaryl polyketide metabolite from S. thioluteus HKI-227, was cloned. 
Successful production of aureothin in a heterologous host S. lividans ZX1 by expression of a 
27 kb region bearing the aur gene set revealed the identity of the aureothin biosynthesis 
gene cluster. Detailed sequence analysis of this surprisingly small region revealed several 
features that are unique in type I PKS catalyzed polyketide assembly, such as a novel 
priming mechanism. In addition, for the first time it is provided direct evidence for the 
programmed iterative use of a single PKS module. 
 
1.5.1 PKS Domain Architecture Implicates a Novel Priming Mechanism 
For bacterial type I PKS that utilize starter units other than acetate or propionate, two priming 
mechanisms are known. Free carboxylic acids may be activated and loaded by a 
nonribosomal peptide synthetase (NRPS)-like adenylation–thiolation (A–T) didomain at the 
N-terminus of the PKS. Alternatively, acyl-CoA ligases may activate the carboxylates as CoA 
thioesters, which are loaded onto the PKS by the type ATL /ACPL loading didomain (Moore et 
al., 2002). Conversely, neither A-T nor ATL /ACPL domains could be identified at the N-
terminus of the first PKS module AurA. A conceivable mechanism could be the activation of 
starter unit by the putative acyl-CoA ligase AurE and direct transfer onto the PKS. A similar 
scenario could be considered for CoA ligase – acyl carrier protein (CoL-ACPL) loading 
didomains, which have been identified in the candicidin, rapamycin (Schwecke et al., 1995) 
and pimaricin (Aparicio et al., 2000) biosynthesis gene clusters. However, since the N-
terminus of AurA lacks the ACP signature motif for phosphopantheinyl-binding, the priming 
mechanism of the aureothin PKS remains puzzling, and  further biochemical studies are 
required to understand this unusual set up. 
 
1.5.2 Five Claisen Condensations Are Catalyzed by Only Four PKS Modules  
A considerable number of bacterial type I PKS gene clusters have been cloned and 
sequenced so far. The discovery that the structure of the polyketide metabolite has a one-to-
one correspondence to the type I PKS architecture serves as a common model for 
understanding the programming of modular polyketide synthases and has provided the 
molecular basis for targeted genetic manipulations. Through detailed sequence analysis and 
heterologous expression of the full set of aureothin biosynthetic genes it has proven that four 
PKS modules are sufficient for the catalysis of five elongation and reduction cycles. Amino 
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acid sequence analysis revealed that module 2, 3 and 4 are responsible for the last three 
rounds of polyketide chain extension. To synthesize the diene substructure of aureothin, the 
first two chain extensions both need a module containing KS, AT, ACP, KR and DH activities. 
In the entire aureothin gene cluster only module 1 could meet this kind of requirement. 
Module architecture and AT specificity strongly suggests that the first module of the 
aureothin PKS, AurA, is used twice.  
Although this finding is contrary to the principle of co-linearity, it may be rationalized in the 
context of a few recent observations. In both natural and engineered polyketide-producing 
organisms, traces of metabolites with C2-elongated polyketide backbones have been 
detected, which do not accurately correspond to the programmed biosynthetic sequence. 
Höfle et al. have isolated ring-enlarged homologues of epothilone from a Sorangium 
cellulosum So ce90 culture broth (Hardt et al., 2001). Leadlay, Staunton and coworkers have 
investigated a mutant strain of the erythromycin producer Saccharopolyspora erythraea that 
produced two novel octaketides in addition to the heptaketide aglykon DEBS, which is the 
major metabolite (Wilkinson et al., 2000). The occurrence of such side products has been 
interpreted by Leadlay et al. as an aberrant repeated use of a module, which is referred to as 
“stuttering”. However, these metabolites are considered as the result of error-prone 
programming of the requisite polyketide synthases and are thus only formed in trace 
amounts. In contrast, during aureothin polyketide assembly the iterative action is a 
programmed event, with exclusive formation of the pentaketide.  
At this stage, it can not be ruled out that AurA may be present in two identical copies (or 
possibly two variants of AurA) docking one behind the other, giving rise to a perfectly 
collinear pentamodular PKS. Alternatively, the repeated use of AurA may be truly iterative, as, 
for example, in fungal PKS or type I fatty acid synthases. On the basis of the current model 
of type I PKS as a helically arranged homodimer (Staunton et al., 1996 and Gokhale et al., 
1998), and considering the domain architecture of AurA, for this model only one mechanism 
seems plausible: the acyl intermediate would be passed back from the ACP onto the 
preceding KS domain, as proposed by Leadlay and Staunton for the biosynthesis of minor 
side products of the erythromycin PKS (Wilkinson et al., 2000).  
In addition to AurA, it might be possible that iteration also occurs in AurC. As sequence 
analyses reveal, the AT4 domain is possibly inactive due to the lacking active site serine; 
furthermore, the specificity region is aberrant. Since module 3 has the same domain 
arrangement as module 4, one may speculate that both final chain extensions are catalyzed 
by module 3 alone, according to the mechanism mentioned above. 
The heterologous aureothin PKS expression experiments provide the yet strongest body of 
evidence that iterative use of a module is an inherent property of a natural PKS. At present, it 
is not possible to deduce the iterative and non-iterative nature of the aur PKS modules by 
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comparison of sequences alone. Furthermore, it is a riddle how this unusual system has 
evolved. Apparently, modular PKS may have an intrinsic ability to work in an iterative fashion, 
as recent heterologous expression experiments of individual PKS modules demonstrate 
(Beck et al., 2003), and possibly the line between iterative and non-iterative PKS is more 
blurred than commonly believed.  
 
2. Functional Analysis of the Aureothin Biosynthesis Gene 
Cluster 
 
2.1      Biosynthetic Pathway of the Rare p-Nitrobenzoate (PNBA) Starter Unit 
for Polyketide Synthesis 
Besides the results of early feeding experiments, the discovery of aurG, a homolog of pabAB, 
also proved the involvement of PABA in the biosynthesis of aureothin. Up to now, there is still 
no information about how and when the amino group of PABA is converted into the nitro 
group of the resulting structure aureothin, and which is the real starter unit for polyketide 
synthesis. In aureothin gene cluster, all gene functions except for aurF were implied by 
homology and fit well into the whole biosynthetic scheme, aside from a gene candidate 
encoding the N-oxidation activity. Surprisingly, the deduced 336 aa gene product (AurF) 
does not show any sequence homologies to known proteins and not even a known cofactor-
binding motif could be determined. It is speculated that aurF may be the candidate encoding 
the N-Oxidase. Further functional study will help us to disclose the real role of AurF and the 
starter unit of polyketide. 
 
2.1.1   Isotope Labelling Experiment 
The structure of nitroaryl moiety in aureothin is very suggestive for PABA or a derivative 
thereof as the starter unit of the polyketide chain assembly. Because so far all efforts to 
incorporate labelled PABA into aureothin failed, and traces of p-nitrobenzoate (PNBA) was 
detected in the crude extract of S. thioluteus HKI-227 culture by ESI-MS analyses, p-
nitrobenzoate (PNBA) was probed as the potential PKS starter. 1 mg d4-PNBA (CDN 
Isotopes) dissolved in 100 µl sterile aqueous DMSO solution, was administered to 100 ml of 
2, 3 or 4 days old M10 liquid cultures of S. thioluteus HKI-227. After incubation at 28°C for 
additional 3 days with vigorous shaking, the cultures were extracted with ethyl acetate. LC-
ESMS and HPLC analyses revealed that d4-PNBA was incorporated in the aureothin 
biosynthesis at a fairly high rate (ca. 20%). The M+4 shift in molecule and daughter ions 
generated by MSn experiments (Fig.3.10) indicated that PNBA acts as the aureothin PKS 
starter unit. 
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Figure 3.10. HPLC profile of S. thioluteus extract and MS-MS analyses of [1+H]+ (m/z=398) and  
[d4-1+H]+ (m/z=402)(insets) obtained by isotope labelling experiments.  
 
2.1.2 Localization of the Putative N-Oxygenase Gene Region by an N-
Oxidation Assay  
It was assumed that PNBA would be synthesized in the aureothin biosynthetic pathway by 
oxidation of PABA, and one PABA synthase gene (aurG) was found in the aureothin gene 
cluster. Strikingly, no obvious gene candidate, which might encode the putative N-oxidation 
activity, could be detected by sequence analysis. From a previous publication (Kawai et al., 
1965), a biotransformation method was found for an N-oxidation assay. In a whole cell 
approach, mycelium of 2 days old Streptomyces culture was harvested, washed and 
resuspended in PBS buffer. PABA was administered to the cell suspension and the extract of 
the liquid portion was detected by TLC and MS to monitor the formation of PNBA after 
reciprocal shaking at 28°C. The major portion of supplied PABA could be readily transformed 
to PNBA within several hours by the wild type strain S. thioluteus HKI-227. In order to screen 
for the obscure N-oxidation activity, several constructs bearing different length of truncated 
gene sets were generated by successive deletion of the 27 kb aur gene cluster from the end 
(Fig.3.11). All constructs were cloned into the shuttle vector pSET152 as the whole gene 
cluster and also expressed in the host S.lividans ZX1, which is not capable of oxidizing 
PABA. As monitored by TLC and MS, aureothin production was completely abolished in all 
truncated mutants, but N-oxidation activity was retained (Table 3.3), even in S. 
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lividans::pHJE01, which only harbours a ca. 6 kb genomic fragment. On this 6 kb region, only 
one ORF (aurF) could not be assigned through database searches, which was assumed to 
be the putative N-oxygenase gene. 
pHJ48 
 
Figure 3.11. Truncated gene sets of the aur gene cluster for localization of the novel N-oxidase 
gene. A large SspI-Eco72I fragment from the aur gene cluster was ligated with the blunt end of the 
integrative shuttle vector pSET152 EcoRV-digested to give the plasmid pHJES. pHJE01 is a subclone 
of pHJES, in which the aurG and aurH genes were eliminated by deletion of the 3.4 kb SgfI fragment 
with digestion and subsequent self-ligation of the residual large fragment. 
 
Table 3.3. Results of the N-oxidation assay and aureothin production of different mutated 
strains. The host strain S. lividans ZX1 and S. lividans ZX1::pHJ48 were used as negative and 
positive control, respectively, for every detection experiment. n.d.: not done. 
 
Strain/Mutant N-Oxidation Activity Aureothin Production 
S. lividans ZX1 – – 
S. lividans ZX1::pHJ48 + + 
S. lividans ZX1::pHJES + – 
S. lividans ZX1::pHJE01 + – 
S. lividans ZX1::pHJ60 + – 
S. lividans ZX1::pHJ79 – – 
S. lividans ZX1::pHJ79+PABA n.d. – 
S. lividans ZX1::pHJ79+PNBA n.d. + 
S. lividans ZX1::pHJ97 + – 
S. lividans ZX1::pHJ97+PABA n.d. + 
S. lividans ZX1::pHJ97+PNBA n.d. + 
 
2.1.3 Heterologous Expression of the Novel N-Oxygenase Gene (aurF)  
The aurF gene including the native ribosome binding site (RBS) was amplified by PCR with 
PrimerFL2 and PrimerFR, and cloned into the pGEM-T Easy Vector for sequencing. The 1.2 
kb EcoRI fragment containing aurF with RBS was recovered from the sequencing vector and 
ligated into the EcoRI site of the Streptomyces expression pWHM4* vector, which possesses 
pHJES 
aurD E F A C G H B I
Eco72I
SgfI SgfI 
pHJE01 
J
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a constitutive promoter (PermE*). The resulting plasmid, pHJ60 (Fig.3.12), was introduced 
into S. lividans ZX1 by PEG-induced protoplast transformation. The transformant was 
fermented and the 2 days old mycelium was harvested for the N-oxidation assay. 
Remarkably, the transformant showed N-oxidation activity at the same level as the wild type 
strain (Fig.3.13). The result of the N-oxidation assay clearly indicated that the unknown gene 
aurF encodes a novel N-oxygenase, which has no homology to any known proteins in the 
databases. Neither common motifs nor cofactor-binding sites could be identified by database 
searches. In order to investigate the protein characteristics and cofactors of AurF, two 
primers, PrimerFL1 and PrimerFR, were designed for amplification of aurF from start codon 
to stop codon. After sequencing, the PCR product was cut out from the sequencing vector by 
NdeI and BamHI digestion and cloned into the corresponding NdeI and BamHI sites of two 
expression vectors pMALTM-c2x or pET-15b, respectively, for protein analyses in vitro. 
Overexpression and purification of the AurF protein are still in progress. 
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Figure 3.12. Construction of pHJ60 for heterologous expression of the aurF gene in S. lividans 
ZX1. The 1.2 kb PCR product including aurF gene and its RBS was cloned into pGEM-T Easy Vector 
to give the plasmid pHJ58. After confirmation by sequencing, the PCR fragment was recovered by 
EcoRI digestion and transferred downstream of the constitutive promoter (PermE*) in the 
Streptomyces expression vector pWHM4* to give the resulting plasmid pHJ60. 
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2.1.6 Discussion 
The biosynthetic origin of the rare nitro aryl moiety from aureothin was elucidated by both 
molecular and chemical approaches. Incorporation of d4-PNBA into aureothin in the feeding 
experiment demonstrated for the first time that PNBA may serve as a polyketide starter unit. 
Cloning, expression and deletion of aurF gene revealed that PABA is transformed into the 
corresponding nitro compound by an unprecedented type of N-oxygenase. Previous results 
and further heterologous expression and inactivation experiments disclosed the biosynthetic 
pathway of this unusual primer. The biosynthesis of PNBA involves a PABA synthase (AurG), 
which converts chorismate acid into PABA, and afterward a novel N-oxygenase (AurF), 
which is responsible for biotransformation from PABA to PNBA (Fig.3.15).  
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Figure 3.15. Biosynthetic model for the starter unit of aureothin.  
 
Though aromatic nitro compounds widely distribute among various organisms, they are in 
fact quite rare in nature. Chloramphenicol (He et al., 2001) and pyrrolnitrin (Arima et al., 1965) 
are two representatives among the most prominent examples. So far, not much is known 
about the biosynthesis of nitro aromatic natural products. In a few cases, the possible source 
of aromatic nitro groups was considered presumably from the substitution reactions (Steglich 
et al., 2002). But it seems that oxidation of primary amines, which probably goes through 
hydroxylamine and nitroso intermediates stages, is more common. As yet, the only example 
of an N-oxidizing enzyme, which has a Rieske motif, has been implicated in the formation of 
the nitro group of pyrrolnitrin (Kirner et al., 1994). Strikingly, in the aureothin gene cluster, the 
deduced 336 amino acid gene product of aurF has no homology to any known oxido-
reductases, and neither common motifs nor cofactor-binding sites could be identified by 
database searches. Inactivation, expression and complementation experiments 
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demonstrated the function of AurF, which catalyzes the oxidation reaction from PABA to 
PNBA.  But so far it is not known that how this enzyme works and which are the cofactors for 
the N-oxidation. Functional research of overexpressed AurF in vitro may reveal the stereo-
structure and nature of the active site and motifs of this protein, and investigate the enzyme 
properties and kinetics as well as its cofactors. 
The vast majority of polyketides is primed with acetate or propionate. However, a number of 
polyketide synthases utilize alternative starter units, such as short-chain branched fatty acids, 
alicyclic and aromatic acids, and amino acids. The nature of the primer unit often provides 
important structural and biological features to the molecule, and variation of the starter unit 
can significantly alter the activity profile of the natural product (Moore et al., 2002). An 
impressive example for alteration of starter unit is the engineered biosynthesis of doramectin, 
a highly potent anthelmintic agent obtained by exchanging the avermectin isobutyrate for 
cyclohexanoate. In order to force PKS to accept the fed non-natural primers, the blocked 
mutant should be an excellent acceptor strain, in which the formation of natural metabolites 
is suppressed by either adding a specific inhibitor of the starter biosynthesis, or by deleting 
particular biosynthetic genes. The tolerance and specificity of different PKS is the 
determinant for the success of the precursor-directed mutasynthesis (Moore et al., 2002). For 
improving the affinity, the unnatural starter maybe needs to be activated by a CoA ligase or 
administered as the corresponding N-acetyl cysteamine (NAC) thioester. This approach has 
been successful for generation analogs of erythromycin (Pacey et al., 1998), rifamycin 
(Hunziker et al., 1998), enterocin and the wailupemycins (Kalaitzis et al., 2003). Here, both of 
the aurF and aurG knock-out mutants, in that the biosynthetic pathway of the particular 
starter unit has been shut down, could be used for mutasynthesis of novel aureothin 
derivatives by feeding a number of non-natural primers as PNBA surrogates. If exogenously 
supplied starter units could be accepted by the aur PKS, the mutant strains would be capable 
of catalyzing propagation and modification of polyketide chain to yield aureothin derivatives 
automatically in vivo. In our lab, an aureothin derivative, aureonitrile, with significant 
cytostatic effect was successfully achieved by employing this strategy (Ziehl et al., in press).  
In addition to employing the rare PNBA starter unit, the aur PKS has some peculiar features, 
such as the absence of an obvious loading domain, which is usually present in conventional 
bacterial type I PKS. So far the priming mechanism without any loading domain as in fungal 
type I PKS or in the aur PKS is still unclear. It is speculated that the starter unit is loaded 
directly onto the KS domain of the first PKS module after activation by the putative acyl-CoA 
ligase AurE. The investigation for the primer specificity of aur PKS and for the substrate 
specificity of AurE protein will shed light on this unusual priming mechanism in aureothin 
biosynthesis. 
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2.2 Post-PKS Modification Reactions 
After release from the PKS, the polyketide carbon chains usually undergo further 
modifications to yield the final biologically active compounds. These additional tailoring 
reactions are performed by various tailoring enzymes invariably encoded by genes adjacent 
to PKS genes (Pfeifer et al., 2001). In aureothin biosynthesis, it can be assumed that 
formation of the homochiral five-membered heterocycle and methylation of pyrone ring are 
post-PKS modification reactions after the polyketide backbone is formed. By sequence 
analysis, a putative methyltransferase gene (aurI) and a putative cytochrome P450 
oxygenase gene (aurH) were detected in the aureothin gene cluster. Both of genes may be 
involved in the post-PKS tailoring reactions of aureothin synthesis. Functional studies will 
disclose the mechanisms of the post-PKS processing. 
 
2.2.1   Knock-Out of the Putative Methyltransferase Gene (aurI) 
In the insert sequence of cosmid pST18E4, only three XhoI sites are present. One is within 
aurI, a gene putatively encoding an O-methyltransferase. The other two are located 
downstream of the aur gene cluster, one of which is within the putative transposase gene 
(aurJ) (Fig.3.16). Elimination of two smaller XhoI fragments, which contain the aurI and aurJ 
genes, could yield a knock-out mutant of the putative methyltransferase gene (aurI) along 
with the loss of aurJ. The DNA of pST18E4 was digested with XhoI and after dilution the 
digestion product was self-ligated using T4 DNA ligase. Two different new constructs were 
detected from transformation clones in the E. coli DH5α host. The first was named pHJ44, 
which lost both XhoI fragments. And the second was designated pHJ45, in which only the 
smallest XhoI fragment bearing the aurI and parts of aurJ was discarded. For heterologous 
expression, the original vector pWEB of these two new constructs was exchanged for the 
shuttle vector pSET152 by transferring the SspI inserts of them. The resulting plasmids, 
pHJ46 (from pHJ44) and pHJ47 (from pHJ45) (Fig.3.16a), were introduced into S. lividans 
ZX1 by protoplast transformation, respectively. Two transformants (S. lividans ZX1::pHJ46 
and S. lividans ZX1::pHJ47) were found to produce the same secondary metabolites as 
monitored by TLC (Fig.3.16b). Both of them are unable to produce aureothin, but two novel 
compounds with higher polarity are formed. TLC and LC-MS analyses of the fluorescent 
fractions of extracts revealed the molecular weight of these two aureothin derivatives, with 
M=369 g/mol possibly nor-deoxyaureothin (main product) and M=385 g/mol possibly nor-
hydroxydeoxyaureothin (minor product). The structures of them (Fig.3.16b) were fully 
elucidated by HR-MS and NMR analyses of purified substances after large scale 
fermentation of S. lividans ZX1::pHJ47 (Markus Müller, unpublished). The absence of the O-
methyl of the pyrone rings in both new metabolites of the aurI knock-out mutant verified the 
function of AurI. Moreover, the lack of or the incomplete furan ring formation hinted at the 
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order of the tailoring steps. Apparently, the O-methylation of the pyrone ring takes place 
before the synthesis of the furan ring. 
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gene encK was also cloned in pWHM4*, yielding plasmid pHJ72 (Fig.3.17). The expression 
of encK in the ∆aurI mutant can also complement aureothin biosynthesis, but the 
complementation in the opposite direction, i.e. expression of aurI in the ∆encK mutant, failed 
(Moore et al., personal communication). 
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Figure 3.18. Biotransformation experiments by expression of AurI enzyme in Streptomyces. 
 
2.2.4 Inactivation of the Putative Cytochrome P450 Oxygenase Gene (aurH) by 
In-Frame Deletion 
To prove the involvement of AurH, a putative cytochrome P450 oxygenase, in the unusual 
oxidative heterocyclization, inactivation of aurH gene was performed by PCR-targeting 
system. As in the deletion of aurG and aurF, the shuttle cosmid pHJ48 bearing the entire aur 
biosynthesis gene cluster served as suitable starting point for generating the aurH knock-out 
mutant directly in E. coli by recombination. Two long primers, aurHL and aurHR, were 
designed to amplify the extended streptomycin and spectinomycin resistance gene (aadA) 
flanked by FRT sites (FLP recognition targets). After introduction into E. coli 
BW25113/pIJ790 containing pHJ48, the PCR product replaced the aurH gene by 
homologous recombination. The central part of the disruption cassette was subsequently 
removed by site-specific recombination of the FLP recombinase in E. coli. In the resulting 
cosmid pHJ98 (Fig.3.19a), only the aurH gene sequence was excised from the aur gene 
cluster and the deletion was confirmed by restriction mapping. After protoplasts of S. lividans 
ZX1 were transformed with the DNA of pHJ98, the resulting transformant, S. lividans 
ZX1::pHJ98, was cultivated in M10 medium under apramycin selection to maintain the 
integration of pHJ98 in the chromosome. TLC, HPLC and MS analyses of the crude extract 
from the mutant broth culture revealed that two other fluorescent metabolites were formed 
instead of aureothin. On TLC plates, the main product deoxyaureothin appeared in lieu of 
aureothin with slightly lower polarity, while the minor product hydroxydeoxyaureothin showed 
much higher polarity. The structures of new metabolites were fully resolved after purification 
of substances from the culture of a 20 l S. lividans ZX1::pHJ98 fermentation by HR-MS and 
NMR analyses (Markus Müller, personal communication). The fact that both novel 
compounds already bear methyl groups in the pyrone ring provided further support for the 
hypothesis of the order of the post-PKS processing. O-methylation is the first post-PKS 
modification reaction and the second modification is the furan ring formation catalyzed by the 
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oxygenase. In aur gene cluster, only two oxygenase genes, aurF and aurH, were detected. 
Heterologous expression and inactivation experiments have already revealed that AurF is 
solely involved in the biosynthesis of the PKS primer. Thus, the best candidate gene product 
for catalyzing the furan ring formation is AurH. Nevertheless, the appearance of the 
unexpected side product, hydroxydeoxyaureothin, is baffling. In order to eliminate the 
interference of other CYT P450 genes from other polyketide gene cluster in host strain S. 
lividans ZX1, pHJ98 was also introduced into another host strain, S. albus, for expression. 
TLC, HPLC and LC-MS data revealed that S. albus::pHJ98 only produced deoxyaureothin 
and no hydroxydeoxyaureothin was found (Fig.3.19b), while the control strain S. 
albus::pHJ48 produced aureothin as expected. It indicated that hydroxydeoxyaureothin is an 
oxygenated derivative of deoxyaureothin by some other oxygenases from the host S. lividans 
ZX1. 
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Figure 3.19. a. Organization of the aur genes in aurH null mutant (p
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(Fig.3.20). When the resulting plasmid pHJ110 was introduced into S. lividans ZX1::pHJ98, 
the mutant was successfully complemented and aureothin biosynthesis was restored.  
aurH RBS 
 
 
Figure 3.20. Construct of pHJ110 for heterologously expressing aurH gene in Streptomyces. 
 
2.2.6 Biotransformation Experiments by Heterologous Expression of aurH 
While inactivation and complementation experiments clearly demonstrated that AurH is 
required for furan ring formation, it needed to be established if this novel cytochrome P450 
oxygenase is indeed sufficient for catalyzing the formation of both C-O bonds of the furan 
moiety. For this purpose, AurH was heterologous expressed in S. lividans ZX1 using 
expression plasmid pHJ110. When deoxyaureothin was administered to the culture, the AurH 
expression strain S. lividans ZX1/pHJ110 could readily catalyze the formation of furan ring to 
give the final product, aureothin, as monitored by LC-MS (Fig.3.21). Furthermore, a side 
product, dehydrodeoxyaureothin, isolated from S. lividans ZX1::pHJ48 was also tested in the 
biotransformation experiment with heterologously expressed AurH, but no transformation 
occurred. 
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Figure 3.21. Biotransformation experiments by expressing AurH protein in Streptomyces. 
 
To study AurH protein in vitro, the aurH gene was amplified from its start codon to the stop 
codon by PCR with two primers, PrimerHL2 and PrimerHR. When the PCR product was 
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cloned into the multiple cloning sites of the E. coli overexpression vector pMALTM-c2x, a malE 
signal sequence encoding the E. coli maltose binding protein was fused to the N-terminal 
end of the aurH gene for purification of the protein. Overexpression and purification of the 
fusion AurH protein are still in progress. 
 
2.2.7 Discussion 
Inactivation, complementation and expression experiments of the different tailoring enzymes, 
AurH and AurI, provided a lot of information not only on their functions, but also on the timing 
of the post-PKS processing. The methyltransferase gene aurI knock-out mutant produces 
nor-deoxyaureothin, not nor-aureothin, while the P450 oxygenase gene aurH knock-out 
mutant produces deoxyaureothin. These results clearly revealed a defined order of the 
tailoring steps. O-methylation is the first modification reaction and synthesis of the furan ring 
represents the last step in the aureothin pathway, which is catalyzed by a bifunctional 
cytochrome P450 monooxygenase, AurH (Fig.3.22).  
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Figure 3.22. Biosynthetic model for tailoring reaction processing. The final ring closure might 
occur through a radical mechanism or through nucleophilic substitution via a bis-hydroxylated 
intermediate. 
 
It is obvious that the final modification step occurs with the subsequent oxidation of two non-
activated carbons. Thus, two scenarios are generally conceivable for this rare oxidation 
sequence: either the allylic position (9a-C) is attacked first (route A, Fig.3.22) or the 
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methylene (7-C) adjacent to the pyrone ring (route B), setting the stereochemistry of the 
resulting heterocycle at an earlier stage. Route B is significantly supported by the occurrence 
of a nitrobenzoate-primed polyketide metabolite, dehydrodeoxyaureothin. This side 
compound is produced by the wild type strain S. thioluteus and by S. lividans ZX1::pHJ48, 
which served for heterologous expression of the entire gene cluster, but not by the ∆aurH 
null mutant (Markus Müller, personal communication). In general, dehydrodeoxyaureothin 
may result from an error-prone β-keto processing of the second module (AurB), where the 
ER domain of module 2 would be accidentally skipped. However, this triene compound could 
not be detected in the ∆aurH null mutant, where the identical PKS is employed. It is thus 
more likely that dehydrodeoxyaureothin is a shunt product from route B, resulting from 
hydroxylation and subsequent dehydration. 
The biotransformation experiment mentioned above revealed that dehydrodeoxyaureothin is 
in fact not a substrate of AurH. Since in this compound the 7-C methylene is masked, but the 
9a-C methyl group is still available, this result could support the model where oxygenation is 
not initiated at the methyl group. All observations point towards the second path in which 
AurH first oxidizes the methylene adjacent to the pyrone ring and then promotes the second 
C-O bond formation, yielding the tetrahydrofuran ring. 
To date, a large number of cytochrome P450 genes from various organisms are known. The 
best studied P450 enzymes play a key role in mammalian liver cells for drug and xenobiotic 
metabolism. Most cytochrome P450 oxygenases in this superfamily are monofunctional, 
catalyzing a single hydroxylation or epoxidation of a substrate. Multifunctional cytochrome 
P450s are rare and yet little explored. For example, the loss of C-14 in steroid biosynthesis 
(Lamb et al., 1999) and the three-step oxidation of ent-kaurene to ent-kaurenoic acid in 
Gibberella fujikuroi (Ashman et al., 1990) have been described as sequential oxidations 
mediated by single cytochrome P450s at the same carbon atom, whereas the oxidation at 
multiple sites by a single P450 enzyme has been reported for mammalian steroid 
biosynthesis (Sun et al., 1995 and Nonaka et al., 1991) and in some secondary products of 
fungi, such as gibberellin (Rojas et al., 2001). Through inactivation and biotransformation 
experiments, it demonstrated that AurH is a multifunctional cytochrome P450 
monooxygenase catalyzing the formation of the homochiral furan ring of aureothin. To our 
knowledge this is the first example of proof for a single P450 monooxygenase catalyzing a 
two-step heterocyclization.  
AurH contains only one single heme-binding motif so that both of C-O bond formations must 
be catalyzed at the same active site. However, the oxidized carbons should be sufficiently 
close, thus requiring only small changes of the substrate-binding orientation when the 
enzyme catalyzes the two sequential oxidation reactions. Further studies with the purified 
AurH protein in vitro will help elucidations of this multifunctional enzyme. 
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During the studies of post-PKS modification, several aureothin derivatives were produced by 
the mutants. As mentioned earlier, tailoring reactions usually can have a marked influence on 
the activity profiles of the final metabolites in polyketide synthesis. Therefore, bioassay of 
these novel compounds would unearth their potentialities for new drug exploitation. So far, 
only deoxyaureothin was tested for bioassay. The antimicrobial profile of deoxyaureothin is 
very similar to aureothin, albeit with slightly reduced antifungal activity. Strikingly though, 
deoxyaureothin exhibits a five-fold increased cytotoxic activity against human K-562 
leukemia cells (Markus Müller, personal communication). 
 
2.3 Investigation of the Aureothin PKS 
In aureothin polyketide synthase, three PKS genes (aurA, aurB and aurC) encode four PKS 
modules terminated with a thioesterase (TE) domain. Strikingly, the N-terminus of the first 
module lacks a loading domain and the AT4 domain is supposed to be inactive due to a 
mutated active site motif. In stark contrast to the accepted principle of co-linearity observed 
for modular type I PKS, heterologous expression experiment demonstrated in aureothin gene 
cluster, only four PKS modules are sufficient for catalyzing five rounds of elongation and 
processing. The domain architecture of the modules suggests that the first module is used 
twice, giving rise to the diene substructure. Furthermore, because of the aberrant and non-
functional AT of module 4, it could be assumed that in analogy to the first module, the 
isosteric module 3 might operate iteratively, too, in order to accomplish the fifth Claisen 
condensation. To prove the iterative fashion of AurA, the aurA gene could be heterologously 
expressed and fused with TE domain at the C-terminus, which could promote the release of 
the intermediate after the extension reactions performed by the first module (AurA). Fusion of 
the aurA gene and its downstream gene, aurB, could also be an alternative strategy.  In 
addition, the inactivation of some key domains in module 4 would disclose if this module is in 
fact functional despite its aberrant AT domain and thus reveal if the module 3 is operating in 
an iterative fashion.  
 
2.3.1   Cloning of the aurA Gene in Streptomyces Expression Vector pRM5 
For functional studies of the first PKS module by obtaining the polyketide intermediate after 
the Claisen condensations catalyzed by AurA, the aurA gene was cloned into the vector 
pRM5, which has been used previously for recombinant PKS expression in heterologous 
Streptomyces host. pRM5 is a shuttle vector, which contains a replication origin from ColE1 
and an antibiotic resistance gene (bla) for convenient manipulation of DNA cloning in E. coli 
host, and SCP2* Streptomyces replicon and an antibiotic gene (tsr) for introduction of 
exogenous DNA into Streptomyces. It has the additional activator gene (actII-ORF4) and 
divergent promoter pair (PactI/actIII) from the act gene cluster for expression of recombinant 
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PKS. A ca. 800 bp fragment including the N-terminal sequence of aurA together with the 
native RBS was amplified by PCR with a pair of primers, ORFL1 and ORFR1, and 
furthermore a PacI site was introduced upstream of the RBS sequence for cloning. After 
cloned into pGEM-T Easy Vector for sequencing, the PCR product was recovered by 
restriction digestion with PacI and Bsp1407I together. The second part of aurA was covered 
by a 4925 bp Bsp1407I-NcoI fragment cut out from pHJ48. This big fragment plus the PCR 
product covers the majority of the aurA gene except that a piece of ACP sequence at the C-
terminus is missing. In order to enhance the effective release of the polyketide intermediate 
after the elongation reaction(s) by AurA, the TE domain sequence of module 4 was also 
amplified by PCR with two primers, TEL1 and TER1. An NcoI site was introduced into the N-
terminus of TE for fusion with AurA. These three components of recombinant aurA+TE were 
assembled and ligated with the larger PacI-EcoRI fragment of pRM5 vector to give the 
plasmid pHJ33. For activation of the starter unit, the acyl CoA ligase gene (aurE) is also 
required. The act KR gene region in pHJ33 was replaced by aurE by exchanging the HindIII-
PacI fragments with a subclone of the aurE gene, yielding the resulting plasmid pHJ41 
(Fig.3.23). After protoplast transformation, the transformant S. lividans ZX1::pHJ41 was 
cultivated in M10 medium and fed with the starter unit PNBA at the second day. By TLC and 
LC-MS analyses, no intermediate of aureothin biosynthesis could be detected. However, 
PNBA that was not consumed for initiation of the polyketide chain still stagnated in the 
extract of the fermentation of the transformant.  
To clone the native aurA gene, a PstI fragment containing the missing ACP part of aurA and 
its downstream gene aurG was cloned into a medi-vector and then recovered by restriction 
digestion with NcoI and EcoRI. This renascent fragment was substituted for the TE domain 
region in pHJ41 to give plasmid pHJ43 (Fig.3.23). The transformant S. lividans ZX1::pHJ43 
fed with PNBA could not produce any detectable nitrobenzoate-primed polyketide 
metabolites either. 
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Figure 3.23. Restriction maps of pHJ41 and pHJ43 for expression of the aurA gene 
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2.3.2 Repositioning TE Domain within the Aureothin PKS 
One attractive method to gain insight into the course of polyketide assembly would be the 
identification of pathway intermediates that are anchored to the thio template during chain 
elongation and processing. In principle, the hydrolytic activity of a C-terminally fused 
thioesterase domain can result in a premature release of the polyketide intermediates, which 
would enable the isolation and elucidation of all pathway intermediates. In the erythromycin 
gene cluster, the TE domain has been successfully repositioned to cause a premature chain 
release (Cortes et al., 1995 and Kao et al., 1995). The viability of this approach depends 
critically on the tolerance of the TE to alternative substrates. In the aureothin gene cluster, 
this method was also adopted to move TE domain in the end of previous PKS module to 
obtain intermediate after every condensation. In the beginning, the appropriately fused 
ACP/TE sequence from the aur gene cluster was used to replace the corresponding ACP 
fragment in the end of each PKS module by homologous recombination. A 1038 bp DNA 
fragment encoding the TE domain and part of the ACP4 domain was amplified by PCR with a 
pair of oligonucleotides, aurATEL and aurATER. Also, a 672 bp HindIII-XhoI fragment was 
amplified as one homologous region of gene replacement constructs by PCR using two 
primers, shortL and shortR. The DNA sequence of the two PCR products was confirmed by 
sequencing after cloning into the pGEM-T Easy Vector. Three fragments of a 534 bp NotI-
FspI region encoding parts of the KR1 and ACP1 domains (for module 1+TE), a 247 bp 
BamHI-FspI region encoding parts of the KR2 and ACP2 domains (for module 1+2+TE), a 
1277 bp BamHI-FspI region encoding parts of the AT3 and ACP3 domains (for module 
1+2+3+TE), were used as the other homologous region for homologous recombination, and 
cloned together with the 1038 bp FspI-EcoRI fragment into NotI-EcoRI-cut (for module 1+TE) 
or BamHI-EcoRI-cut (for module 1+2+TE and module 1+2+3+TE) pBluescript II SK(-) vector, 
respectively. The 672 bp HindIII-XhoI fragment and a 2340 bp SmaI fragment containing the 
streptomycin and spectinomycin resistance gene (aadA) for selection of recombinants were 
inserted into three preceding pBluescript II SK(-) derivatives in succession to give the gene 
replacement constructs. The whole inserts of three gene replacement constructs, recovered 
from the pBluescript II SK(-) vector, were purified from agarose gel and introduced into E. coli 
BW25113/pIJ790 containing cosmid pHJ48 by electroporation to perform a double cross-
over mediated by the λ Red system. In these three resulting plasmids, pHJ125, pHJ126 and 
pHJ127 (Fig.3.24), the TE domain has been placed downstream of module 1, 2 and 3, 
respectively. However, all resulting mutants that express truncated variants of the aur PKS 
were incapable of polyketide production. The reason for the non-working truncated PKS 
might be the high substrate specificity of the aur TE domain.  
In another attempt, the heterologous TE domain from the erythromycin gene cluster was 
used to construct analogous variants of the aur PKS. The ery TE sequence plus a part of the 
Results and Discussion 77
adjacent ACP region was amplified by PCR with two primers, PrimerEryL and PrimerEryR, 
from the erythromycin producer, Saccharopolyspora erythraea, to substitute the aur ACP/TE 
region and to construct truncated variants of the aur PKS in analogy the above cloning 
procedure. Unfortunately, all constructs were unable to produce any polyketide metabolites. 
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Figure 3.24. Organization of the aur genes in recombinant PKS constructed by repositioning 
the TE domain. Bars indicate a small fragment of module 4 amplified by PCR as the homologous 
region for recombination. 
 
2.3.3 Fusion of AurA (Module 1) and AurB (Module 2) 
Although the aur gene cluster encodes only four PKS modules for five rounds of chain 
extensions, which strongly suggests that module 1 is used twice, the possibility had to be 
excluded that two copies of AurA might assemble head to tail to yield a perfectly collinear 
pentamodular PKS. To prove the iterative nature of AurA, the aurA and aurB genes were 
fused. In the case of a covalent attachment of the C-terminus of AurA (module 1) with the N-
terminus of AurB (module 2), the occurrence of a twin AurA protein could be ruled out. A 
similar strategy has recently proven successful for the iterative borrelidin PKS, where genes 
were fused at the appropriate start/stop codons (Olano et al., 2003). Conversely, in this study 
another strategy was used to accomplish the desired gene fusion. In order to prevent any 
incompatibility of the linker region, parts of ACP1 and KS2 were replaced with parts of ACP3 
and KS4 including the interdomain region. The high similarity of ACP1 and ACP3, KS2 and 
KS4, appeared ideally suited for the target substitution of partial PKS regions without 
affecting the functions of the catalytic domains. Several cloning steps were required to yield 
the desired construct. First, a subclone containing the aurC gene was used as template for 
PCR to amplify the ACP3-KS4 interdomian region, introducing two restriction sites, PstI and 
SgfI, which were suitable for executing the subsequent substitution. Second, from an E. coli 
– Streptomyces shuttle cosmid pHJ48 bearing the entire aur biosynthesis gene cluster, a 
large unique KpnI fragment (ca. 15 kb) was excised and subcloned. After exchanging the 
biggest PstI-SgfI fragment (3997 bp) with the PstI-SgfI fragment (269 bp) obtained by PCR, 
aurD E F G H B module3+TE A 
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the altered KpnI fragment was reverted to the shuttle cosmid and the correct direction of the 
insert was ascertained by restriction digestion. In the resulting construct pHJ86, aurA and 
aurB were fused in-frame into the same translational unit, while aurG and aurH were 
eliminated (Fig.3.25). After introduction of pHJ86 by conjugation into S. albus, the 
transconjugant S. albus::pHJ86 was selected for apramycin resistance and cultivated. As the 
PABA synthase and P450 monooxygenase genes (aurG and aurH) were eliminated along 
with the gene fusion, the PABA derived PKS primer PNBA was administered to the culture in 
order to enable polyketide biosynthesis. TLC, HPLC and MS analyses of the crude extract 
from a plate culture revealed the formation of a novel metabolite, deoxyaureothin, an 
aureothin derivative lacking the tetrahydrofurant ring (Fig.3.26), which has already been 
identified as product of the ∆aurH mutant. The production of deoxyaureothin is rationalized 
by the loss of the aurH gene along with the gene fusion. The successful expression of the 
AurAB fusion protein with concomitant production of deoxyaureothin clearly rules out the 
possibility that two copies of AurA are forming a twin module. In addition to the domain 
architecture of AurA, this result provides strong evidence for the iterative use of module 1 
during the formation of the diene moiety. 
 
KpnI 
 
 
Figure 3.25. Construction of the engineered plasmid (pHJ86) resulting from gene fusion. The 
ACP3-KS4 interdomain was amplified by PCR with introducing two restriction sites, PstI and SgfI, and 
substituted for the native PstI-SgfI fragment in a subclone of the KpnI fragment. The altered KpnI 
fragment was reverted to the shuttle cosmid to give the resulting construct, pHJ86. Bars indicate the 
ACP3-KS4 interdomain area. 
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Figure 3.26. Model for deoxyaureothin biosynthesis by a bimodular fusion protein. 
 
2.3.4 Fusion of AurA (Module 1) and AurC (Module 3 and 4) 
The successful fusion of aurA and aurB encouraged another attempt to fuse aurA (module 1) 
and aurC (module 3 and 4) together in order to investigate whether AurA could transfer the 
polyketide intermediate to AurC directly and if so, how many rounds of polyketide elongation 
AurA could catalyze. By using a related strategy, parts of ACP1 and KS3 were replaced with 
parts of ACP3 and KS4 including the interdomain region. The ACP3-KS4 interdomain region 
was amplified by PCR with two primers, LinkerL and LinkerR2 and two restriction sites, PstI 
and AccIII, were introduced into two primers for the following substitution. After exchanging 
the large PstI-AccIII fragment (10607 bp) with the PstI-AccIII fragment (326 bp) obtained by 
PCR, the altered KpnI fragment was ligated into the KpnI sites of the shuttle cosmid pHJ48 
and the resulting plasmid, pHJ137, was checked by restriction digestion to verify the correct 
insert direction. In this new fusion construct, not only aurG and aurH, but also aurB (module 
2) were eliminated along with the gene fusion. TLC and MS analyses revealed that the 
transconjugant S. albus::pHJ137 could not produce any nitrobenzoate-primed polyketides 
even in the presence of administered PNBA. Suppose the assembly line of the polyketide 
chain was blocked in the resulting shortened PKS, because of the high substrate specificity 
of AurC or due to an incorrect folding of the mutated PKS. 
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2.3.5 Site-Directed Mutagenesis of the KS4 and ACP4 Domains 
In addition to AurA, it was assumed that iteration also occurs in the third module. As 
sequence analyses revealed, the AT4 domain shows only weak homology to known AT 
domains and is possibly inactive due to the lacking active site serine. Since module 3 has the 
same domain arrangement as module 4, it was tempting to speculate that both final chain 
extensions are catalyzed by module 3 alone. In order to investigate if module 4 is required for 
the final chain elongation, site-directed mutagenesis experiments of the KS and ACP active 
sites were performed. The target regions for mutation were the conserved motifs housing the 
active site cysteine of KS (VDTACSSS) and the phosphopantheinyl binding site serine of 
ACP (GFDSL).  As previous work on the erythromycin PKS demonstrated, a cysteine to 
alanine or serine to alanine mutation, respectively, yields inactive PKS domains, but does not 
affect expression or folding of the enzyme (Thomas et al., 2002). Both manipulations in the 
aur PKS were achieved by exchanging gene fragments encoding the KS4 and ACP4 
domains with the mutated complements (Fig.3.27).  
For inactivation of KS4, a PvuII site was introduced into the active site. The mutated KpnI-
Bsu36I DNA fragment encoding parts of KS4* and AT4 domains was assembled with two 
different PCR products, a KpnI-PvuII fragment encoding the N-terminal region and a PvuII-
Bsu36I fragment encoding the C-terminal region. In the junction, the KS4 active site cysteine 
residue was replaced by alanine and a PvuII site was introduced in the region encoding the 
active site to change the cysteine codon into an alanine codon. After exchanging the naive 
DNA fragment with the mutated KpnI-Bsu36I fragment in cosmid pHJ48, the resulting 
plasmid, pHJ146, was introduced into protoplasts of S. lividans ZX1 by transformation and 
into S. albus by conjugation.  
The same strategy was also used for inactivation of the ACP4 domain. Here, an AflIII site 
was introduced at the region encoding the phosphopantheinyl attachment site to change the 
serine codon into an alanine codon. The mutated Bsu36I-XbaI fragment encoding parts of 
AT4*, ACP4 and TE domains was assembled from two PCR products, an EcoRI-AflIII 
fragment and an AflIII-XbaI fragment. In the junction, the ACP active site serine codon was 
mutated to an alanine codon through introduction of an AflIII site. After substituting the native 
region with the mutated Bsu36I-XbaI fragment in cosmid pHJ48, the resulting plasmid 
pHJ144 was introduced into S. lividans ZX1 and S. albus.  
Two transformants, S. lividans ZX1::pHJ144 and S. lividans ZX1::pHJ146 and two 
transconjugants, S. albus::pHJ144 and S. albus::pHJ146, were fermented under the same 
conditions as the native aureothin producers. However, thorough TLC, HPLC and MS 
analyses revealed that neither aureothin nor a derivative thereof was formed by any of the 
mutants. In both cases, inactivation the KS or ACP domains of module 4 clearly resulted in a 
shutdown of polyketide biosynthesis (Fig.3.27). Consequently, module 4 is in fact required for 
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the fifth chain elongation of aureothin polyketide production despite its aberrant and probably 
non-functional AT domain. Thus, an iterative use of module 3 is not taking place. 
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Figure 3.27. Inactivation of KS4 and ACP4 to prove the involvement of module 4. 
 
2.3.6 Construction of an aurA Null Mutant and Complementation Experiment 
The iterative nature of the first module (AurA) of aureothin biosynthesis has been 
unequivocally proven by an engineered gene fusion and heterologous expression of the 
entire gene cluster. However, sequence comparisons of non-iterative and iterative PKS do 
not reveal what is the reason for the repeated use of the first module. Only AurA is self-
sufficient for the iteration or this is the cooperation of AurA and AurB? Perhaps because of 
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the substrate specificity of AurB, only the polyketide chain resulting from two elongation 
reactions catalyzed by AurA could enter into the latter extension steps to yield the resultant 
product, aureothin. In order to investigate the substrate of AurB and prepare a suitable host 
for engineering hybrid AurA or coexpressing other PKS, a construct which contains the whole 
aureothin gene cluster except for the aurA gene was made by gene deletion. 
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Figure 3.28. Coexpression of the aurA null mutant with aurA on pHJ43 to restore the aureothin 
biosynthesis. 
 
The aurA null mutant was constructed by PCR-targeting system. Two long primers, aurAL 
and aurAR, were employed to amplify the extended aadA gene flanked by FRT sites. The 
PCR product was introduced into E. coli BW25113/pIJ790 containing cosmid pHJ48 and 
subsequent gene replacement of the aurA gene by the extended antibiotic resistance 
cassette automatically occurred under the enhanced function of λ Red system. The inserted 
cassette was then removed through the expression of the FLP recombinase. In the resulting 
plasmid, pHJ111, the entire aurA gene was in-frame deleted except for the start (ATG) and 
stop (TAG) codons. After introducing pHJ111 into S. lividans ZX1 by protoplast 
transformation, TLC, HPLC and MS analyses confirmed that the transformant S. lividans 
ZX1::pHJ111 could produce neither aureothin nor any derivatives. When pHJ43, in which the 
aurA gene was cloned into a Streptomyces self-replication vector (pRM5) for expression, 
was introduced into the protoplasts of transformant S. lividans ZX1::pHJ111, the aureothin 
biosynthesis was restored (Fig.3.28). The identity of the aureothin metabolite was 
aurD 
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A E C F G H B I J
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undoubtedly proven with standard aureothin as a reference by TLC, HPLC and MS. 
Construction of the aurA null mutant and its complementation experiments are the 
prerequisite for investigating the substrate specificity of AurB by feeding different synthetic 
intermediates. In the aurA null mutant, only aurA was deleted, but other genes in the aur 
gene cluster are still available. If AurB would accept a suitable substrate from feeding 
experiments, the polyketide biosynthetic pathway would result in the formation of aureothin. 
By cooperation with a colleague, Nelly Traitcheva, the norA gene from the neoaureothin 
biosynthesis gene cluster, which shows very high identity to aurA, was coexpressed in the 
aurA null mutant. The cross complementation with norA also restored the aureothin 
biosynthesis. 
 
2.3.7 Discussion 
In contrast to aromatic polyketide synthases, as well as plant and fungal PKS, type I module 
PKS constitute a processing line along which the polyketide backbone is assembled and 
processed. Usually the number of modules strictly mirrors the number of elongation and 
reduction cycles. This one-to-one correspondence of the polyketide metabolite to the 
modular type I PKS architecture has been accepted as a principle in the programming of 
modular polyketide synthases and has provided the molecular basis for targeted genetic 
engineering resulting in natural product derivatives (Staunton et al., 2001 and Walsh 2002 
and Cane et al., 1998). Nevertheless, the PKS programming can be error-prone. For 
example, the unusual behaviour of “stuttering” and “skipping” phenomena, where a module is 
used repeatedly or omitted during chain elongation, were observed in the ring-enlarged and 
ring-contracted side products from large-scale fermentations of the erythromycin (Wilkinson 
et al., 2000 and Thomas et al., 2002) and epothilone producer (Hardt et al., 2001), 
respectively. While the erythromycin and epothilone derivatives are obviously the results of 
an erratic processing of the PKS, recent observations provide growing evidence that iteration 
or stuttering can in fact be a programmed event encoded by the modular polyketide synthase. 
The first genomic indication for an iterative use of a single PKS module was reported by the 
group of R. Müller who found that a gene encoding a PKS module is missing in the 
stigmatellin (Fig.3.29) gene cluster from Stigmatella aurantiaca. Since the lacking PKS gene 
could not be detected elsewhere in the genome by hybridization, it was concluded that one 
PKS module would be compensated by the repeated use of a functionally equivalent module, 
either StiH or StiJ (Gaitatzis et al., 2002). 
In this work, the aureothin biosynthesis gene cluster was cloned and sequenced. According 
to the principle of co-linearity, five PKS modules would be required for the assembly of the 
polyketide backbone. However, sequence analyses and heterologous expression of the 
entire aur gene cluster revealed that four modules are sufficient for catalyzing five rounds of 
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elongation and processing. Expression of the AurAB fusion protein and the domain 
architecture unequivocally revealed that the first module is used twice, giving rise to the 
diene substructure.  
Almost simultaneously with these findings, the Salas and Leadlay groups jointly 
communicated that in borrelidin (bor) (Fig.3.29) biosynthesis a single elongation module is 
used even three times (Olano et al., 2003). While classical modular PKS show a one-to-one 
correspondence between PKS architecture and polyketide product, the novel sti, aur and bor 
PKS systems clearly breach with the generally accepted principle of co-linearity. However, 
sequence comparisons of non-iterative and iterative PKS do not point towards the molecular 
ground for iteration, and to date the reason why PKS act iteratively or non-iteratively remains 
a mystery.  
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Figure 3.29. Chemical structure of stigmatellin and borrelidin. 
 
For gaining a deeper insight into the intriguing code of the aur PKS, several attempts 
including the expression of the hybrid AurA+TE and the repositioning of the TE domain in the 
downstream region of each PKS module were made to investigate the course of polyketide 
assembly. However, all efforts expressing truncated PKS variants failed. This could be 
explained by a high substrate specificity of the TE or by an incorrect folding of the mutated 
PKS. Also, the failure of expressing the AurAC fusion protein could be due to the similar 
reason. 
Point mutations of the KS4 and ACP4 domains, which result in a shutdown of polyketide 
biosynthesis, excluded the possibility of the iteration of module 3. Even if the AT4 domain is 
aberrant and supposed to be inactive, module 4 is still required for the last elongation step. 
How can this observation be rationalized? Recently, J. Piel reported on the surprising 
discovery of a type I PKS from a pederus bacterial symbiont, where all PKS modules are 
lacking AT domains (Piel, 2002). This novel PKS system is served by iterative acyl 
transferases in trans, which are also encoded in the same gene cluster. Similar findings have 
been made in other more recent cases, i.e. the leinamycin (Cheng et al., 2003) and the 
mupirucin (El-Sayed et al., 2003) PKS. Interestingly, apparently non-functional AT domain 
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have also been identified in cis-AT PKS systems, such as the pyoluteorin PKS (Nowak-
Thompson et al., 1999 and 2003), as well as the neocarzilin PKS, which represents the most 
recent example of an iterative modular PKS (Otsuka et al., 2004). In these cases, as in the 
aur PKS, it remains a riddle how the anomalous AT domains function or how they might be 
complemented. 
Now, the whole biosynthetic pathway of the aureothin biosynthesis (Fig.4.1) can be clearly 
portrayed by summarizing all the results from sequence analyses and functional studies of 
the aur gene cluster. First, chorismate acid is converted into PABA by AurG. Subsequently, 
PABA is oxidized into PNBA by AurF, a novel N-oxygenase. The unusual PKS starter unit, 
PNBA, is activated by AurE and then loaded directly onto the PKS to initiate the polyketide 
chain elongations. Surprisingly, the first PKS module, AurA, catalyzes two rounds of 
elongation cycles during the polyketide assembly. After the polyketide chain is released from 
the TE domain, the first post-PKS tailoring step, O-methylation of the pyrone ring, is 
performed by AurI, and then a bifunctional P450 oxygenase, AurH, catalyzes the formation of 
the homochiral furan ring, yielding the resultant product, aureothin. 
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D. Summary 
Aureothin is a rare nitroaryl-substituted metabolite from the soil bacterium Streptomyces 
thioluteus, which exhibits a variety of biological activities, including antifungal, antitumoral and 
insecticidal. Early labelling studies revealed that aureothin is composed of an unknown starter 
unit, one acetate and four propionate units. By construction and screening of a S. thioluteus 
HKI-227 genomic cosmid library, the aureothin (aur) gene cluster was cloned and sequenced. 
The identity of the aur gene cluster was proven by heterologous expression. Detailed 
sequence analyses revealed that aureothin is synthesized by an unusual modular type I 
polyketide synthase (PKS), which has several exceptional features, including a novel priming 
mechanism and the iterative use of one module. Typically, modular type I PKS are arranged 
in an assembly line fashion, harboring a catalytic domain for each biosynthetic step. In stark 
contrast to this accepted principle of co-linearity, sequence analyses and heterologous 
expression of the aur gene cluster demonstrated that only four modules are sufficient for 
catalyzing five rounds of polyketide chain extensions. The engineered fusion of the first two 
PKS genes and the domain architecture unequivocally revealed that the first module 
catalyzes two successive cycles of chain extension, one of the first examples of a modular 
PKS, in which such iteration is required to produce the normal polyketide product. 
Furthermore, point mutants of the KS4 (ketosynthase) and ACP4 (acyl carrier protein) 
domains revealed that module 4 is in fact required for the last chain elongation despite its 
aberrant and probably non-functional acyl transferase (AT) domain. Further functional 
analyses of the aur biosynthesis gene cluster disclosed the whole biosynthetic pathway of 
aureothin. 
The biosynthetic origin of the rare nitro aryl moiety from aureothin was elucidated using both 
molecular and chemical approaches. Incorporation of d4-p-nitrobenzoate (d4-PNBA) into 
aureothin in a feeding experiment demonstrated for the first time that PNBA may serve as a 
polyketide starter unit. Cloning, expression and deletion of aurF gene revealed that 
p-nitrobenzoate (PABA) is transformed into the corresponding nitro compound by an 
unprecedented type of N-oxygenase (AurF), which could represent the first member of a new 
family of oxidizing enzymes.  
Furthermore, the order of the tailoring reactions was elucidated by inactivation, 
complementation and expression of the putative tailoring enzymes. AurI catalyzes the 
O-methylation of the pyrone ring. AurH is a multifunctional cytochrome P450 monooxygenase 
catalyzing the formation of the homochiral furan ring of aureothin, which constitutes the last 
step in the aureothin biosynthetic pathway.  
In addition to elucidating the unusual biosynthetic pathway of aureothin, mutants were 
generated that produce aureothin derivatives, some of which show enhanced biological 
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activities compared to aureothin, such as deoxyaureothin with increased cytotoxic activity. In 
addition, the genetic engineering of the aur gene cluster has set the basis for the 
mutasynthesis of aureonitrile, an aureothin derivative with significantly improved cytostatic 
effects.  
Further studies on the detailed mechanism of the unusual iterative modular aur PKS system 
will provide new insights into the molecular basis and the evolutionary relationship of iterative 
and non-iterative polyketide synthases and set the ground for engineering novel unnatural 
natural aureothin derivatives. 
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Figure 4.1. Model of non-linear aureothin biosynthesis from chorismate. 
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E. Zusammenfassung 
Aureothin ist ein außergewöhnliches Nitroaryl-substituiertes Polyketid, das von dem 
Bodenbakterium Streptomyces thioluteus produziert wird und eine Vielzahl biologischer 
Aktivitäten (u.a. antifungisch, zytostatisch, insektizid) aufweist. Klassische Labeling-Studien 
zeigten, dass Aureothin aus einem unbekannten Starter, einer Acetat- und vier 
Propionat-Einheiten zusammengesetzt ist.  
Zur Klonierung und Sequenzierung des Aureothin (aur) Genklusters, wurde eine genomische 
Cosmidbibliothek von S. thioluteus HKI-227 konstruiert und gescreent. Detaillierte 
Sequenzanalysen des aur Genklusters zeigten, dass Aureothin von einer außergewöhnlichen 
modularen Typ I Polyketidsynthase (PKS) synthetisiert wird. Neben einem neuartigen 
Priming-Mechanismus und der Nutzung von p-Nitrobenzoat (PNBA) als Starteinheit, ist hier 
besonders die wiederholte Nutzung eines Moduls der Aureothin-Synthase herauszustellen.  
Im Gegensatz zu gewöhnlichen bakteriellen Typ I Polyketidsynthasen, die für jeden 
Biosyntheseschritt eine katalytische Domäne besitzen, enthält die aur PKS für die fünf 
durchzuführenden Polyketid-Kettenverlängerungen nur vier Module. Durch heterologe 
Expression des aur Genklusters konnte gezeigt werden, dass die gesamte genetische 
Information für die Aureothin Biosynthese auf diesen vier Modulen vorhanden ist. 
Ergänzend zur heterologen Expression konnte durch die Fusion der ersten beider PKS Gene 
eindeutig demonstriert werden, dass ein Modul zwei aufeinanderfolgende 
Kettenverlängerungszyklen katalysiert. Die aur PKS stellt damit eines der ersten Beispiele für 
eine iterative oder „stotternde“ bakterielle Typ I PKS dar.  
Trotz einer aberranten und wahrscheinlich nicht-funktionalen Acyltransferase 
(AT)-Domäne, bestätigten Punktmutationen in der KS4 (Ketosynthase )- und der 
ACP4 (Acylcarrierprotein)- Domäne, dass das Modul 4 für den letzten 
Kettenverlängerungsschritt verantwortlich ist. 
Weitere Funktionsanalysen des Genklusters trugen dazu bei, den Aurethin-Biosyntheseweg 
näher zu verstehen. 
Die biosynthetische Herkunft der seltenen Nitroaryl-Gruppe des Aureothins wurde sowohl 
durch molekulare als auch durch chemische Methoden untersucht. Der Einbau von d4-PNBA 
in Aureothin in Fütterungsexperimente bestätigte zum ersten mal, dass PNBA als 
Polyketid-Startereinheit genutzt werden kann. Klonierung, Expression und Deletion des aurF 
Gens zeigte, dass p-Aminobenzoesäure (PABA) durch eine bisher unbekannte N-Oxygenase 
(AurF) in die entsprechende Nitro-Verbindung überführt wird. AurF repräsentiert das erste 
Mitglied einer neuen Familie von oxidierenden Enzymen. 
Weiterhin wurde der Ablauf der Tailoring-Reaktionen durch Inaktivierung, Komplementierung 
und Expression der Tailoring-Enzyme untersucht. Die O-Methyltransferase AurI katalysiert die 
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O-Methylierung des Pyronringes. AurH, eine multifunktionale Cytochrom P450 
Monooxygenase, katalysiert die Formation des homochiralen Furanringes und damit den 
letzten Schritt in der Aureothin Biosynthese. 
Neben der Funktionsaufklärung des aur Genclusters führten die gezielten Mutanten zur 
Produktion verschiedener Aureothin-Derivate mit verändertem Wirkprofil, wie z.B. 
Deoxyaureothin mit erhöhter Zytotoxizität. Zudem bildeten Mutagenesestudien die Grundlage 
für die Mutasynthese von Aureonitril, einem Aureothin-Derivat mit signifikant erhöhtem 
zytostatischen Effekt. 
Das weitere Studium des detaillierten Mechanismus und der Evolution des ungewöhnlichen 
modularen aur PKS – Systems wird neue Einblicke in das Rätsel des „Stotterns“ gewähren 
und damit die Grundlage für die biotechnologische Erzeugung neuer Verbindungen bilden. 
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